KR101506761B1 - Organic compound and organic electroluminescent devices using the same - Google Patents
Organic compound and organic electroluminescent devices using the same Download PDFInfo
- Publication number
- KR101506761B1 KR101506761B1 KR1020110141688A KR20110141688A KR101506761B1 KR 101506761 B1 KR101506761 B1 KR 101506761B1 KR 1020110141688 A KR1020110141688 A KR 1020110141688A KR 20110141688 A KR20110141688 A KR 20110141688A KR 101506761 B1 KR101506761 B1 KR 101506761B1
- Authority
- KR
- South Korea
- Prior art keywords
- synthesis
- group
- inv
- dihydrocarbazolo
- mmol
- Prior art date
Links
- 0 Oc(c(*1c2ccc(c(-c3c(*4c5ccccc5)cccc3)c4cc3)c3c2-c2c1cccc2)c(c(O)c1O)O)c1O Chemical compound Oc(c(*1c2ccc(c(-c3c(*4c5ccccc5)cccc3)c4cc3)c3c2-c2c1cccc2)c(c(O)c1O)O)c1O 0.000 description 6
- VTFMOMAQLFTOBK-UHFFFAOYSA-N c(cc1)cc2c1[nH]c1c2cc(cc2[nH]c3ccccc3c2c2)c2c1 Chemical compound c(cc1)cc2c1[nH]c1c2cc(cc2[nH]c3ccccc3c2c2)c2c1 VTFMOMAQLFTOBK-UHFFFAOYSA-N 0.000 description 2
- WNNWDROTTNPCSJ-UHFFFAOYSA-N c(cc1)cc2c1[nH]c1c2ccc(cc2)c1c1c2c2ccccc2[nH]1 Chemical compound c(cc1)cc2c1[nH]c1c2ccc(cc2)c1c1c2c2ccccc2[nH]1 WNNWDROTTNPCSJ-UHFFFAOYSA-N 0.000 description 2
- IOPQERQQZZREDR-UHFFFAOYSA-N Brc1cc(-c2ccccc2)cc(-c2ccccc2)c1 Chemical compound Brc1cc(-c2ccccc2)cc(-c2ccccc2)c1 IOPQERQQZZREDR-UHFFFAOYSA-N 0.000 description 1
- INJYATWDDJSOIP-UHFFFAOYSA-N Brc1nc(-c2ccccc2)cc(-c2ccccc2)c1 Chemical compound Brc1nc(-c2ccccc2)cc(-c2ccccc2)c1 INJYATWDDJSOIP-UHFFFAOYSA-N 0.000 description 1
- JTTXDXLCMPUBES-UHFFFAOYSA-N C=[Br]c1cncc2ccccc12 Chemical compound C=[Br]c1cncc2ccccc12 JTTXDXLCMPUBES-UHFFFAOYSA-N 0.000 description 1
- AWXMPFIFBHHVSR-UHFFFAOYSA-N Fc(cc1)cc(c2c3ccc4c2ccc2c4c4cc(F)ccc4[n]2-c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c1[n]3-c1cc(cccc2)c2cc1 Chemical compound Fc(cc1)cc(c2c3ccc4c2ccc2c4c4cc(F)ccc4[n]2-c2nc(-c4ccccc4)nc(-c4ccccc4)n2)c1[n]3-c1cc(cccc2)c2cc1 AWXMPFIFBHHVSR-UHFFFAOYSA-N 0.000 description 1
- MCBXIQNEEOZNCT-UHFFFAOYSA-N N#Cc(cc1)cc(c2c3ccc4c(c(cc(cc5)C#N)c5[n]5-c(nc6)ccc6-c6cccnc6)c5ccc24)c1[n]3-c1cc(-c2ccccc2)nc(-c2ccccc2)c1 Chemical compound N#Cc(cc1)cc(c2c3ccc4c(c(cc(cc5)C#N)c5[n]5-c(nc6)ccc6-c6cccnc6)c5ccc24)c1[n]3-c1cc(-c2ccccc2)nc(-c2ccccc2)c1 MCBXIQNEEOZNCT-UHFFFAOYSA-N 0.000 description 1
- LWRQFNKDEGYIIZ-UHFFFAOYSA-N [O-][N+](c(cccc1)c1-c1ccc(ccc(-c2ccccc2[N+]([O-])=O)c2)c2c1)=O Chemical compound [O-][N+](c(cccc1)c1-c1ccc(ccc(-c2ccccc2[N+]([O-])=O)c2)c2c1)=O LWRQFNKDEGYIIZ-UHFFFAOYSA-N 0.000 description 1
- JFGAWJMTHMBHRF-UHFFFAOYSA-N c(cc1)cc2c1[nH]c1c2cc(cc(c(cccc2)c2[nH]2)c2c2)c2c1 Chemical compound c(cc1)cc2c1[nH]c1c2cc(cc(c(cccc2)c2[nH]2)c2c2)c2c1 JFGAWJMTHMBHRF-UHFFFAOYSA-N 0.000 description 1
- AYXCNFFNTNZZQN-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(cc1)ccc1-c1ccccn1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(cc1)ccc1-c1ccccn1 AYXCNFFNTNZZQN-UHFFFAOYSA-N 0.000 description 1
- VQKGMYBKYXVJNQ-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(cc1)ccc1-c1cccnc1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(cc1)ccc1-c1cccnc1 VQKGMYBKYXVJNQ-UHFFFAOYSA-N 0.000 description 1
- WWPDZZGCLKFGQE-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(cc1)ccc1-c1nc(cccc2)c2[n]1-c1ccccc1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(cc1)ccc1-c1nc(cccc2)c2[n]1-c1ccccc1 WWPDZZGCLKFGQE-UHFFFAOYSA-N 0.000 description 1
- HYXBNPHNYLTUIL-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(nc1)ccc1-c1cccnc1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(nc1)ccc1-c1cccnc1 HYXBNPHNYLTUIL-UHFFFAOYSA-N 0.000 description 1
- FQNQDIBFZXDKJS-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(nc1)ccc1-c1ccncc1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c(nc1)ccc1-c1ccncc1 FQNQDIBFZXDKJS-UHFFFAOYSA-N 0.000 description 1
- LYUDVJLRADVYJO-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3c4cccc3)c2cc1[n]4-c(nc1)ccc1-c1cccnc1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3c4cccc3)c2cc1[n]4-c(nc1)ccc1-c1cccnc1 LYUDVJLRADVYJO-UHFFFAOYSA-N 0.000 description 1
- GAYGVEKDDVQBOP-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3c4cccc3)c2cc1[n]4-c(nc1)ccc1-c1ccncc1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3c4cccc3)c2cc1[n]4-c(nc1)ccc1-c1ccncc1 GAYGVEKDDVQBOP-UHFFFAOYSA-N 0.000 description 1
- KMIGQHXGTLBMPO-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3ccccc33)c2cc1[n]3-c(cc1)ccc1-c1ccccn1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3ccccc33)c2cc1[n]3-c(cc1)ccc1-c1ccccn1 KMIGQHXGTLBMPO-UHFFFAOYSA-N 0.000 description 1
- LDBQNLRGCDZLCN-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3ccccc33)c2cc1[n]3-c1cccc(-c2cccnc2)c1 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3ccccc33)c2cc1[n]3-c1cccc(-c2cccnc2)c1 LDBQNLRGCDZLCN-UHFFFAOYSA-N 0.000 description 1
- QPDCELLETCETRZ-UHFFFAOYSA-N c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3ccccc33)c2cc1[n]3-c1cccc2c1[s]c1ccccc21 Chemical compound c(cc1)ccc1-[n](c(cccc1)c1c1c2)c1cc(cc1c3ccccc33)c2cc1[n]3-c1cccc2c1[s]c1ccccc21 QPDCELLETCETRZ-UHFFFAOYSA-N 0.000 description 1
- UCJAYIWAPPKGFW-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc11)c(cc2)c1c(cc1)c2c(c2c3cccc2)c1[n]3-c1nccc(-c2cccnc2)c1 Chemical compound c(cc1)ccc1-[n](c1ccccc11)c(cc2)c1c(cc1)c2c(c2c3cccc2)c1[n]3-c1nccc(-c2cccnc2)c1 UCJAYIWAPPKGFW-UHFFFAOYSA-N 0.000 description 1
- ZKLSVOBPPFMCGK-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc11)c(cc2)c1c(cc1)c2c(c2ccccc22)c1[n]2-c1c(cccc2)c2cnc1 Chemical compound c(cc1)ccc1-[n](c1ccccc11)c(cc2)c1c(cc1)c2c(c2ccccc22)c1[n]2-c1c(cccc2)c2cnc1 ZKLSVOBPPFMCGK-UHFFFAOYSA-N 0.000 description 1
- XGVSWTBQPOCGIW-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc11)c(ccc2c3c4c5cccc4)c1c2ccc3[n]5-c1ccnc(-c2cccnc2)n1 Chemical compound c(cc1)ccc1-[n](c1ccccc11)c(ccc2c3c4c5cccc4)c1c2ccc3[n]5-c1ccnc(-c2cccnc2)n1 XGVSWTBQPOCGIW-UHFFFAOYSA-N 0.000 description 1
- PTPWXXYKYLDHKH-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc11)c2c1c1ccc3[nH]c(cccc4)c4c3c1cc2 Chemical compound c(cc1)ccc1-[n](c1ccccc11)c2c1c1ccc3[nH]c(cccc4)c4c3c1cc2 PTPWXXYKYLDHKH-UHFFFAOYSA-N 0.000 description 1
- CKMZQZHVOIFRHP-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c1c2[s]c(cccc3)c3c2ccc1 Chemical compound c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c1c2[s]c(cccc3)c3c2ccc1 CKMZQZHVOIFRHP-UHFFFAOYSA-N 0.000 description 1
- HARQGGDSEYCPDP-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c1cc(-c2cnccc2)ccc1 Chemical compound c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c1cc(-c2cnccc2)ccc1 HARQGGDSEYCPDP-UHFFFAOYSA-N 0.000 description 1
- FSBFRSXFCYHJQN-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c1nc(-c2ccncc2)ccc1 Chemical compound c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc(cc1)c2c2c1c1ccccc1[n]2-c1nc(-c2ccncc2)ccc1 FSBFRSXFCYHJQN-UHFFFAOYSA-N 0.000 description 1
- SLHXOVCNJMRNKT-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc(cc1c3c4cccc3)c2cc1[n]4-c(cc1)ccc1-c1cccnc1 Chemical compound c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc(cc1c3c4cccc3)c2cc1[n]4-c(cc1)ccc1-c1cccnc1 SLHXOVCNJMRNKT-UHFFFAOYSA-N 0.000 description 1
- WKJZHVVQHPSJGM-UHFFFAOYSA-N c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc1c2cc(c(cccc2)c2[n]2-c3nccc(-c4cccnc4)c3)c2c1 Chemical compound c(cc1)ccc1-[n](c1ccccc1c1c2)c1cc1c2cc(c(cccc2)c2[n]2-c3nccc(-c4cccnc4)c3)c2c1 WKJZHVVQHPSJGM-UHFFFAOYSA-N 0.000 description 1
- VBSLILXCOLONLV-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(c(c(cc2)c3)cc4c3c(cccc3)c3[n]4-c(cc3)ccc3-c3cccnc3)c2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c(c(c(cc2)c3)cc4c3c(cccc3)c3[n]4-c(cc3)ccc3-c3cccnc3)c2c2ccccc12 VBSLILXCOLONLV-UHFFFAOYSA-N 0.000 description 1
- UUAGRYJVZVFIDY-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(c(c(cc2)c3)cc4c3c(cccc3)c3[n]4-c3nc4ccccc4cc3)c2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c(c(c(cc2)c3)cc4c3c(cccc3)c3[n]4-c3nc4ccccc4cc3)c2c2ccccc12 UUAGRYJVZVFIDY-UHFFFAOYSA-N 0.000 description 1
- DVHJOGUSGVQRAQ-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(c(c(cc2)ccc3c4c5cccc4)c3[n]5-c3cnc(cccc4)c4c3)c2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c(c(c(cc2)ccc3c4c5cccc4)c3[n]5-c3cnc(cccc4)c4c3)c2c2ccccc12 DVHJOGUSGVQRAQ-UHFFFAOYSA-N 0.000 description 1
- AOKRNNRJUMINTQ-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(c(c(cc2)ccc3c4c5cccc4)c3[n]5-c3cncc4c3cccc4)c2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c(c(c(cc2)ccc3c4c5cccc4)c3[n]5-c3cncc4c3cccc4)c2c2ccccc12 AOKRNNRJUMINTQ-UHFFFAOYSA-N 0.000 description 1
- SXQJWZASKJSIGU-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(c(c(cc2)ccc3c4ccccc44)c3[n]4-c(cc3)ccc3-c3cncc4c3cccc4)c2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c(c(c(cc2)ccc3c4ccccc44)c3[n]4-c(cc3)ccc3-c3cncc4c3cccc4)c2c2ccccc12 SXQJWZASKJSIGU-UHFFFAOYSA-N 0.000 description 1
- ZQYSCSSNLMWNEU-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(c(c2c(cc3)c(cccc4)c4[nH]2)c3cc2)c2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c(c(c2c(cc3)c(cccc4)c4[nH]2)c3cc2)c2c2ccccc12 ZQYSCSSNLMWNEU-UHFFFAOYSA-N 0.000 description 1
- JGUAHWYYMAALCF-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(cc(c2c(cc3)c4ccccc4[n]2-c2ccnc(-c4cccnc4)n2)c3c2)c2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c(cc(c2c(cc3)c4ccccc4[n]2-c2ccnc(-c4cccnc4)n2)c3c2)c2c2ccccc12 JGUAHWYYMAALCF-UHFFFAOYSA-N 0.000 description 1
- QEEXXAGASGCYOY-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(cc(cc(c(c2ccccc22)c3)[n]2-c2ccnc(-c4cccnc4)n2)c3c2)c2c2c1cccc2 Chemical compound c(cc1)ccc1-[n]1c(cc(cc(c(c2ccccc22)c3)[n]2-c2ccnc(-c4cccnc4)n2)c3c2)c2c2c1cccc2 QEEXXAGASGCYOY-UHFFFAOYSA-N 0.000 description 1
- NUHPETYSORZXIN-UHFFFAOYSA-N c(cc1)ccc1-[n]1c2c(cc(c(c3ccccc33)c4)[n]3-c3cccc(-c(cc5)cnc5-c(cc5)cc(c(ccc6c7)c8c6cc6c7c(cccc7)c7[n]6-c6cccc7c6[s]c6ccccc76)c5[n]8-c5ccccc5)n3)c4ccc2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c2c(cc(c(c3ccccc33)c4)[n]3-c3cccc(-c(cc5)cnc5-c(cc5)cc(c(ccc6c7)c8c6cc6c7c(cccc7)c7[n]6-c6cccc7c6[s]c6ccccc76)c5[n]8-c5ccccc5)n3)c4ccc2c2ccccc12 NUHPETYSORZXIN-UHFFFAOYSA-N 0.000 description 1
- UUTMBALZLMSULI-UHFFFAOYSA-N c(cc1)ccc1-[n]1c2cc(c3c(cc4)c5ccccc5[n]3-c3nccc(-c5cccnc5)c3)c4cc2c2c1cccc2 Chemical compound c(cc1)ccc1-[n]1c2cc(c3c(cc4)c5ccccc5[n]3-c3nccc(-c5cccnc5)c3)c4cc2c2c1cccc2 UUTMBALZLMSULI-UHFFFAOYSA-N 0.000 description 1
- CLPXSMBYENBIRD-UHFFFAOYSA-N c(cc1)ccc1-c(c1c2cccc1)cnc2-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 Chemical compound c(cc1)ccc1-c(c1c2cccc1)cnc2-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 CLPXSMBYENBIRD-UHFFFAOYSA-N 0.000 description 1
- MLWXMCLSBSOMEG-UHFFFAOYSA-N c(cc1)ccc1-c(c1c2cccc1)cnc2-[n]1c(cc(cc(c2ccccc2[n]2-c3ccccc3)c2c2)c2c2)c2c2ccccc12 Chemical compound c(cc1)ccc1-c(c1c2cccc1)cnc2-[n]1c(cc(cc(c2ccccc2[n]2-c3ccccc3)c2c2)c2c2)c2c2ccccc12 MLWXMCLSBSOMEG-UHFFFAOYSA-N 0.000 description 1
- VTQPVXUIQZYBEM-UHFFFAOYSA-N c(cc1)ccc1-c(cc1)ccc1-[n](c1ccccc11)c(cc2)c1c(cc1)c2c(c2c3cccc2)c1[n]3-c1ccccc1 Chemical compound c(cc1)ccc1-c(cc1)ccc1-[n](c1ccccc11)c(cc2)c1c(cc1)c2c(c2c3cccc2)c1[n]3-c1ccccc1 VTQPVXUIQZYBEM-UHFFFAOYSA-N 0.000 description 1
- IPUVOXHSMQOZGD-UHFFFAOYSA-N c(cc1)ccc1-c(cc1)ccc1-[n]1c(c(c(cc2)c3)cc4c3c3ccccc3[n]4-c3ccccc3)c2c2ccccc12 Chemical compound c(cc1)ccc1-c(cc1)ccc1-[n]1c(c(c(cc2)c3)cc4c3c3ccccc3[n]4-c3ccccc3)c2c2ccccc12 IPUVOXHSMQOZGD-UHFFFAOYSA-N 0.000 description 1
- SLMCXOWECOQTCL-UHFFFAOYSA-N c(cc1)ccc1-c(cc1)ccc1-[n]1c(cc(cc(c(c2ccccc22)c3)[n]2-c2ccccc2)c3c2)c2c2c1cccc2 Chemical compound c(cc1)ccc1-c(cc1)ccc1-[n]1c(cc(cc(c(c2ccccc22)c3)[n]2-c2ccccc2)c3c2)c2c2c1cccc2 SLMCXOWECOQTCL-UHFFFAOYSA-N 0.000 description 1
- HGZPHAWVVXZNCX-UHFFFAOYSA-N c(cc1)ccc1-c(cc1)cnc1-[n](c(cc1)c2cc1-c1ncccc1)c(ccc1c3c4c5ccc(-c6ccccn6)c4)c2c1ccc3[n]5-c1nc(-c2ccccc2)cc(-c2ccccc2)c1 Chemical compound c(cc1)ccc1-c(cc1)cnc1-[n](c(cc1)c2cc1-c1ncccc1)c(ccc1c3c4c5ccc(-c6ccccn6)c4)c2c1ccc3[n]5-c1nc(-c2ccccc2)cc(-c2ccccc2)c1 HGZPHAWVVXZNCX-UHFFFAOYSA-N 0.000 description 1
- BSRGBDUGOBYOIX-UHFFFAOYSA-N c(cc1)ccc1-c(cc1)nnc1-[n](c1ccccc1c1c2)c1cc(cc1c3c4cccc3)c2cc1[n]4-c1ccccc1 Chemical compound c(cc1)ccc1-c(cc1)nnc1-[n](c1ccccc1c1c2)c1cc(cc1c3c4cccc3)c2cc1[n]4-c1ccccc1 BSRGBDUGOBYOIX-UHFFFAOYSA-N 0.000 description 1
- GFSNZKCYBNLYNA-UHFFFAOYSA-N c(cc1)ccc1-c(cc1)nnc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 Chemical compound c(cc1)ccc1-c(cc1)nnc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 GFSNZKCYBNLYNA-UHFFFAOYSA-N 0.000 description 1
- HWBLOIQECGNPRJ-UHFFFAOYSA-N c(cc1)ccc1-c(nc1)ccc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 Chemical compound c(cc1)ccc1-c(nc1)ccc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 HWBLOIQECGNPRJ-UHFFFAOYSA-N 0.000 description 1
- ATXINVABWJEQQU-UHFFFAOYSA-N c(cc1)ccc1-c(nc1)ncc1-[n]1c(cc(c2c(cc3)c(cccc4)c4[n]2-c2ccccc2)c3c2)c2c2c1cccc2 Chemical compound c(cc1)ccc1-c(nc1)ncc1-[n]1c(cc(c2c(cc3)c(cccc4)c4[n]2-c2ccccc2)c3c2)c2c2c1cccc2 ATXINVABWJEQQU-UHFFFAOYSA-N 0.000 description 1
- UBKNDAFJWMKQQM-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-[n](c2ccccc2c2c3)c2cc(cc2c4c5cccc4)c3cc2[n]5-c2ccccc2)cnn1 Chemical compound c(cc1)ccc1-c1cc(-[n](c2ccccc2c2c3)c2cc(cc2c4c5cccc4)c3cc2[n]5-c2ccccc2)cnn1 UBKNDAFJWMKQQM-UHFFFAOYSA-N 0.000 description 1
- RGMTWZURIGKODG-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-[n](c2ccccc2c2cc3c4)c2cc3cc2c4c(cccc3)c3[n]2-c2cnc(-c3ccccc3)nc2)cc(-c2ccccc2)n1 Chemical compound c(cc1)ccc1-c1cc(-[n](c2ccccc2c2cc3c4)c2cc3cc2c4c(cccc3)c3[n]2-c2cnc(-c3ccccc3)nc2)cc(-c2ccccc2)n1 RGMTWZURIGKODG-UHFFFAOYSA-N 0.000 description 1
- IAXNGSDTBRYISI-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-[n]2c(c3c(cc4)cc(c(cccc5)c5[n]5-c6ccccc6)c5c3)c4c3ccccc23)cc(-c2ccccc2)c1 Chemical compound c(cc1)ccc1-c1cc(-[n]2c(c3c(cc4)cc(c(cccc5)c5[n]5-c6ccccc6)c5c3)c4c3ccccc23)cc(-c2ccccc2)c1 IAXNGSDTBRYISI-UHFFFAOYSA-N 0.000 description 1
- UWTFOWNPVVHIPC-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-[n]2c(cc(cc(c(c3ccccc33)c4)[n]3-c3ccccc3)c4c3)c3c3c2cccc3)cc(-c2ccccc2)c1 Chemical compound c(cc1)ccc1-c1cc(-[n]2c(cc(cc(c(c3ccccc33)c4)[n]3-c3ccccc3)c4c3)c3c3c2cccc3)cc(-c2ccccc2)c1 UWTFOWNPVVHIPC-UHFFFAOYSA-N 0.000 description 1
- WJUOSOCCMNYPSE-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-[n]2c(cc(cc(c(c3ccccc33)c4)[n]3-c3nccc(-c5cccnc5)c3)c4c3)c3c3c2cccc3)cc(-c2ccccc2)n1 Chemical compound c(cc1)ccc1-c1cc(-[n]2c(cc(cc(c(c3ccccc33)c4)[n]3-c3nccc(-c5cccnc5)c3)c4c3)c3c3c2cccc3)cc(-c2ccccc2)n1 WJUOSOCCMNYPSE-UHFFFAOYSA-N 0.000 description 1
- XPALPUFYOHPRTH-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-[n]2c3ccc(c(c4c5ccc(N(c6ccccc6)c6ccccc6)c4)c(cc4)[n]5-c(cc5)cnc5-c5ccccc5)c4c3c3c2ccc(N(c2ccccc2)c2ccccc2)c3)nc(-c2ccccc2)c1 Chemical compound c(cc1)ccc1-c1cc(-[n]2c3ccc(c(c4c5ccc(N(c6ccccc6)c6ccccc6)c4)c(cc4)[n]5-c(cc5)cnc5-c5ccccc5)c4c3c3c2ccc(N(c2ccccc2)c2ccccc2)c3)nc(-c2ccccc2)c1 XPALPUFYOHPRTH-UHFFFAOYSA-N 0.000 description 1
- WDTTYFXOCLXDER-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-[n]2c3ccc(c(c4ccccc44)c(cc5)[n]4-c4ccccc4)c5c3c3c2cccc3)cc(-c2ccccc2)c1 Chemical compound c(cc1)ccc1-c1cc(-[n]2c3ccc(c(c4ccccc44)c(cc5)[n]4-c4ccccc4)c5c3c3c2cccc3)cc(-c2ccccc2)c1 WDTTYFXOCLXDER-UHFFFAOYSA-N 0.000 description 1
- BXRWHHGLVPAEEQ-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-c2ccccc2)cc(-[n](c(cccc2)c2c2c3)c2cc(cc2c4ccccc44)c3cc2[n]4-c2cc(-c3ccccc3)cc(-c3ccccc3)n2)c1 Chemical compound c(cc1)ccc1-c1cc(-c2ccccc2)cc(-[n](c(cccc2)c2c2c3)c2cc(cc2c4ccccc44)c3cc2[n]4-c2cc(-c3ccccc3)cc(-c3ccccc3)n2)c1 BXRWHHGLVPAEEQ-UHFFFAOYSA-N 0.000 description 1
- KYZMPDZMITZPCT-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-c2ccccc2)cc(-[n](c(cccc2)c2c2c3)c2cc2c3cc3[nH]c4ccccc4c3c2)c1 Chemical compound c(cc1)ccc1-c1cc(-c2ccccc2)cc(-[n](c(cccc2)c2c2c3)c2cc2c3cc3[nH]c4ccccc4c3c2)c1 KYZMPDZMITZPCT-UHFFFAOYSA-N 0.000 description 1
- BJUXOCVTTQYCNR-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-c2ccccc2)nc(-[n](c2c3cccc2)c(cc2)c3c(cc3)c2c(c2ccccc22)c3[n]2-c2ccccc2)c1 Chemical compound c(cc1)ccc1-c1cc(-c2ccccc2)nc(-[n](c2c3cccc2)c(cc2)c3c(cc3)c2c(c2ccccc22)c3[n]2-c2ccccc2)c1 BJUXOCVTTQYCNR-UHFFFAOYSA-N 0.000 description 1
- OCWTYKIXLRMJNM-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-c2ccccc2)nc(-[n]2c(c3c(cc4)cc(c(cccc5)c5[n]5-c6ccccc6)c5c3)c4c3c2cccc3)c1 Chemical compound c(cc1)ccc1-c1cc(-c2ccccc2)nc(-[n]2c(c3c(cc4)cc(c(cccc5)c5[n]5-c6ccccc6)c5c3)c4c3c2cccc3)c1 OCWTYKIXLRMJNM-UHFFFAOYSA-N 0.000 description 1
- RCELYXDVQMNGPV-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-c2ccccc2)nc(-[n]2c(cc(cc(c(c3ccccc33)c4)[n]3-c3ccccc3)c4c3)c3c3c2cccc3)c1 Chemical compound c(cc1)ccc1-c1cc(-c2ccccc2)nc(-[n]2c(cc(cc(c(c3ccccc33)c4)[n]3-c3ccccc3)c4c3)c3c3c2cccc3)c1 RCELYXDVQMNGPV-UHFFFAOYSA-N 0.000 description 1
- YGKLAQTVEVHZHI-UHFFFAOYSA-N c(cc1)ccc1-c1ccc(-[n]2c(c(cc3c4c5cccc4)c(cc4)cc3[n]5-c3ccccc3)c4c3ccccc23)nc1 Chemical compound c(cc1)ccc1-c1ccc(-[n]2c(c(cc3c4c5cccc4)c(cc4)cc3[n]5-c3ccccc3)c4c3ccccc23)nc1 YGKLAQTVEVHZHI-UHFFFAOYSA-N 0.000 description 1
- ADUMABFBGFWPLI-UHFFFAOYSA-N c(cc1)ccc1-c1cccc(-[n]2c(c(cc3c4ccccc44)c(cc5)cc3[n]4-c3ccccc3)c5c3ccccc23)n1 Chemical compound c(cc1)ccc1-c1cccc(-[n]2c(c(cc3c4ccccc44)c(cc5)cc3[n]4-c3ccccc3)c5c3ccccc23)n1 ADUMABFBGFWPLI-UHFFFAOYSA-N 0.000 description 1
- SBCPEOZCKCMVTQ-UHFFFAOYSA-N c(cc1)ccc1-c1ccnc(-[n]2c(c(cc3c4ccccc44)c(cc5)cc3[n]4-c3ccccc3)c5c3ccccc23)c1 Chemical compound c(cc1)ccc1-c1ccnc(-[n]2c(c(cc3c4ccccc44)c(cc5)cc3[n]4-c3ccccc3)c5c3ccccc23)c1 SBCPEOZCKCMVTQ-UHFFFAOYSA-N 0.000 description 1
- XWROJVMLWDDNMU-UHFFFAOYSA-N c(cc1)ccc1-c1cnc(-[n](c(cc2)c3cc2N(c2ccccc2)c2ccccc2)c(ccc2c4c5c6ccc(N(c7ccccc7)c7ccccc7)c5)c3c2ccc4[n]6-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)nc1 Chemical compound c(cc1)ccc1-c1cnc(-[n](c(cc2)c3cc2N(c2ccccc2)c2ccccc2)c(ccc2c4c5c6ccc(N(c7ccccc7)c7ccccc7)c5)c3c2ccc4[n]6-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)nc1 XWROJVMLWDDNMU-UHFFFAOYSA-N 0.000 description 1
- OJOZZAXKFPCVIX-UHFFFAOYSA-N c(cc1)ccc1-c1cnc(-[n](c2ccccc2c2c3)c2cc(cc2c4ccccc44)c3cc2[n]4-c2ccccc2)nc1 Chemical compound c(cc1)ccc1-c1cnc(-[n](c2ccccc2c2c3)c2cc(cc2c4ccccc44)c3cc2[n]4-c2ccccc2)nc1 OJOZZAXKFPCVIX-UHFFFAOYSA-N 0.000 description 1
- KIDUGFNPNCYOBY-UHFFFAOYSA-N c(cc1)ccc1-c1cnc(-[n]2c(c(cc3c4c5cccc4)c(cc4)cc3[n]5-c3ccccc3)c4c3ccccc23)nc1 Chemical compound c(cc1)ccc1-c1cnc(-[n]2c(c(cc3c4c5cccc4)c(cc4)cc3[n]5-c3ccccc3)c4c3ccccc23)nc1 KIDUGFNPNCYOBY-UHFFFAOYSA-N 0.000 description 1
- MKUMNCILDGCIGJ-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-[n]2c(cc(cc(c(c3c4cccc3)c3)[n]4-c4cccc(-c5cccnc5)c4)c3c3)c3c3c2cccc3)ccn1 Chemical compound c(cc1)ccc1-c1nc(-[n]2c(cc(cc(c(c3c4cccc3)c3)[n]4-c4cccc(-c5cccnc5)c4)c3c3)c3c3c2cccc3)ccn1 MKUMNCILDGCIGJ-UHFFFAOYSA-N 0.000 description 1
- ACIPHJUGHSYNIW-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-[n]2c3c(c4c(cc5)c(cccc6)c6[n]4-c4ccccc4)c5ccc3c3c2cccc3)ccn1 Chemical compound c(cc1)ccc1-c1nc(-[n]2c3c(c4c(cc5)c(cccc6)c6[n]4-c4ccccc4)c5ccc3c3c2cccc3)ccn1 ACIPHJUGHSYNIW-UHFFFAOYSA-N 0.000 description 1
- AHENUMZPUIVVET-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-c2ccccc2)nc(-c(cc2)ccc2-[n]2c(c(cc3c4c5cccc4)c(cc4)cc3[n]5-c3ccccc3)c4c3ccccc23)n1 Chemical compound c(cc1)ccc1-c1nc(-c2ccccc2)nc(-c(cc2)ccc2-[n]2c(c(cc3c4c5cccc4)c(cc4)cc3[n]5-c3ccccc3)c4c3ccccc23)n1 AHENUMZPUIVVET-UHFFFAOYSA-N 0.000 description 1
- DJSWMIXEJPASOG-UHFFFAOYSA-N c(cc1)ccc1-c1nc(cccc2)c2[n]1-c(cc1)ccc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 Chemical compound c(cc1)ccc1-c1nc(cccc2)c2[n]1-c(cc1)ccc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 DJSWMIXEJPASOG-UHFFFAOYSA-N 0.000 description 1
- IEPJZMGLOVWRIL-UHFFFAOYSA-N c(cc1)ccc1-c1ncc(-[n]2c3c(c4c(cc5)c6ccccc6[n]4-c4ccccc4)c5ccc3c3c2cccc3)nc1 Chemical compound c(cc1)ccc1-c1ncc(-[n]2c3c(c4c(cc5)c6ccccc6[n]4-c4ccccc4)c5ccc3c3c2cccc3)nc1 IEPJZMGLOVWRIL-UHFFFAOYSA-N 0.000 description 1
- HTUOYLULOYQPNS-UHFFFAOYSA-N c(cc1)ccc1-c1nnc(-c2ccccc2)[n]1-c(cc1)ccc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 Chemical compound c(cc1)ccc1-c1nnc(-c2ccccc2)[n]1-c(cc1)ccc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 HTUOYLULOYQPNS-UHFFFAOYSA-N 0.000 description 1
- ILQMDNKAFFFJRG-UHFFFAOYSA-N c(cc1)ccc1-c1nnc(-c2ccccc2)[n]1-c(cc1)ccc1-[n]1c(cc(cc(c(c2c3cccc2)c2)[n]3-c3ccnc(-c4cccnc4)n3)c2c2)c2c2ccccc12 Chemical compound c(cc1)ccc1-c1nnc(-c2ccccc2)[n]1-c(cc1)ccc1-[n]1c(cc(cc(c(c2c3cccc2)c2)[n]3-c3ccnc(-c4cccnc4)n3)c2c2)c2c2ccccc12 ILQMDNKAFFFJRG-UHFFFAOYSA-N 0.000 description 1
- KYVZJKNJAGHEBK-UHFFFAOYSA-N c(cc1)ccc1-c1nncc(-[n]2c(c(cc3c4ccccc44)c(cc5)cc3[n]4-c3ccccc3)c5c3ccccc23)c1 Chemical compound c(cc1)ccc1-c1nncc(-[n]2c(c(cc3c4ccccc44)c(cc5)cc3[n]4-c3ccccc3)c5c3ccccc23)c1 KYVZJKNJAGHEBK-UHFFFAOYSA-N 0.000 description 1
- RUUVDJLBSBJGOA-UHFFFAOYSA-N c(cc1)ccc1N(c1ccccc1)c(cc1)ccc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 Chemical compound c(cc1)ccc1N(c1ccccc1)c(cc1)ccc1-[n]1c(c(cc2c3c4cccc3)c(cc3)cc2[n]4-c2ccccc2)c3c2ccccc12 RUUVDJLBSBJGOA-UHFFFAOYSA-N 0.000 description 1
- WRKUAZMUNQRXCO-UHFFFAOYSA-N c(cc1)ccc1N(c1ccccc1)c(cc1c2c3ccc4c(c(cc(cc5)N(c6ccccc6)c6ccccc6)c5[n]5-c6nc(-c7ccncc7)ccc6)c5ccc24)ccc1[n]3-c1cc(cccc2)c2cc1 Chemical compound c(cc1)ccc1N(c1ccccc1)c(cc1c2c3ccc4c(c(cc(cc5)N(c6ccccc6)c6ccccc6)c5[n]5-c6nc(-c7ccncc7)ccc6)c5ccc24)ccc1[n]3-c1cc(cccc2)c2cc1 WRKUAZMUNQRXCO-UHFFFAOYSA-N 0.000 description 1
- LJXSVMCTXRANNV-UHFFFAOYSA-N c(cc1c2cc(cc(c(c3ccccc33)c4)[n]3-c3cc5ccccc5nc3)c4cc22)ccc1[n]2-c1cc(cccc2)c2nc1 Chemical compound c(cc1c2cc(cc(c(c3ccccc33)c4)[n]3-c3cc5ccccc5nc3)c4cc22)ccc1[n]2-c1cc(cccc2)c2nc1 LJXSVMCTXRANNV-UHFFFAOYSA-N 0.000 description 1
- RZOHRLDHWMSOGY-UHFFFAOYSA-N c1c(-[n]2c(c(c(cc3)ccc4c5c6cccc5)c4[n]6-c4ccccc4)c3c3ccccc23)[s]c2ccccc12 Chemical compound c1c(-[n]2c(c(c(cc3)ccc4c5c6cccc5)c4[n]6-c4ccccc4)c3c3ccccc23)[s]c2ccccc12 RZOHRLDHWMSOGY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/15—Hole transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/17—Carrier injection layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/342—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K2101/00—Properties of the organic materials covered by group H10K85/00
- H10K2101/10—Triplet emission
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Electroluminescent Light Sources (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은 신규한 유기 발광 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것으로, 보다 구체적으로는 정공 주입, 정공 수송, 발광 재료로서 사용되는 신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자에 관한 것이다.BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel organic light emitting compound and an organic electroluminescent device including the same. More particularly, the present invention relates to a novel organic light emitting compound used for hole injection, hole transport, .
Description
본 발명은 유기 전계 발광 소자용 재료로서 사용될 수 있는 신규 유기 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic compound that can be used as a material for an organic electroluminescence device and an organic electroluminescence device including the same.
1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광(electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구는 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시되었다. 이후 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. A study on organic electroluminescent (EL) devices (hereinafter simply referred to as "organic EL devices") led to blue electroluminescence using anthracene single crystals in 1965, starting from the observation of organic thin film luminosity of Bernanose in the 1950s, (Tang) and a functional layer of a light emitting layer. In order to produce high efficiency and high number of organic EL devices, the organic EL device has been developed to introduce each characteristic organic material layer in the device, leading to the development of specialized materials used therefor.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때, 유기물층으로 사용되는 물질은 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the anode, and electrons are injected into the organic layer from the cathode. When the injected holes and electrons meet, an exciton is formed. When the exciton falls to the ground state, light is emitted. The material used as the organic material layer may be classified into a light emitting material, a hole injecting material, a hole transporting material, an electron transporting material, and an electron injecting material depending on functions.
발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 물질로서 호스트/도판트 계를 사용할 수 있다. 도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이때, 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있기 때문에, 인광 도판트 뿐만 아니라 인광 호스트 재료들에 대한 연구가 많이 진행되고 있다. The luminescent material can be classified into blue, green and red luminescent materials according to luminescent colors and yellow and orange luminescent materials necessary for realizing better natural colors. Further, in order to increase the color purity and to increase the luminous efficiency through energy transfer, a host / dopant system can be used as a luminescent material. The dopant material can be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. At this time, since the phosphorescent material can theoretically improve the luminous efficiency up to 4 times as compared with the fluorescent material, researches on phosphorescent host materials as well as phosphorescent dopants have been conducted.
현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층으로는 NPB, BCP, Alq3 등이 널리 알려져 있으며, 발광 재료로는 안트라센 유도체들이 형광 도판트/호스트 재료로서 보고되고 있다. 특히, 발광 재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료들은 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색(blue), 녹색(green), 적색(red) 도판트 재료로 사용되고 있으며, 현재까지는 CBP가 인광 호스트 재료로 높은 특성을 나타내고 있다.Up to now, hole injecting layer, hole transporting layer. NPB, BCP, and Alq 3 are widely known as the hole blocking layer and the electron transporting layer, and anthracene derivatives as a luminescent material have been reported as fluorescent dopant / host material. In particular, the phosphor has a great advantage in improving the efficiency aspects of the light-emitting material materials Firpic, Ir (ppy) 3, (acac) Ir (btp) 2 Ir metal complex compound is blue (blue), which includes the same as the green ( green and red dopant materials, and CBP is a phosphorescent host material.
그러나 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아 OLED 소자에서의 수명 측면에서 만족할 만한 수준이 되지 못하는 실정이다. 따라서 더욱 성능이 뛰어난 재료의 개발이 요구되고 있다.However, existing materials have advantages in terms of light emitting properties, but they are not satisfactory in terms of lifetime in OLED devices because of low glass transition temperature and poor thermal stability. Therefore, development of materials with higher performance is required.
본 발명은 높은 유리 전이온도로 인해 우수한 열적 안정성을 갖는 신규 유기 화합물을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a novel organic compound having an excellent thermal stability due to a high glass transition temperature.
또, 본 발명은 상기 신규 유기 화합물을 포함하여 구동전압, 발광효율 등이 향상된 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.It is another object of the present invention to provide an organic electroluminescent device including the novel organic compound and having improved driving voltage, luminous efficiency, and the like.
본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:The present invention provides a compound represented by the following formula (1): < EMI ID =
상기 화학식 1에서, In Formula 1,
A 및 B는 각각 치환 또는 비치환된 6-원(membered)의 환(cycle)을 의미하고;A and B are each a substituted or unsubstituted six-membered cycle;
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3~40의 헤테로시클로알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5~60의 헤테로아릴기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C60의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C6~C60의 아릴실릴기, 또는 치환 또는 비치환된 C6~C60의 아릴아민기이며,Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 3 to C 40 cycloalkyl group, a substituted or unsubstituted heterocyclic group having 3 to 40 nuclear atoms An alkyl group, a substituted or unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkyloxy group, hwandoen C 6 ~ C 60 aryloxy group, a substituted or unsubstituted C 1 ~ C 40 alkyl silyl group, a substituted or unsubstituted C 6 ~ C 60 aryl silyl group, or a C 6 unsubstituted or substituted in the the aryl amine group of 60 ~ C,
이때 상기 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기 및 아릴아민기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3~40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5~60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되되, 복수개의 치환기는 각각 동일하거나 상이할 수 있으며;At this time, one or more substituents respectively introduced into the alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group and arylamine group are each independently selected from deuterium , A cyano group, a C 1 to C 40 alkyl group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms Group, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, and a C 6 to C 60 arylamine group, wherein the plurality of substituents may be the same or different;
R1 내지 R8은 각각 독립적으로 수소, 중수소, 할로겐, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C60의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C6~C60의 아릴실릴기, 또는 치환 또는 비치환된 C6~C60의 아릴아민기이고,R 1 to R 8 each independently represent hydrogen, deuterium, halogen, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 3 to C 40 cycloalkyl group, a substituted or unsubstituted nucleus atom number A substituted or unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkyl aryloxy group, arylsilyl a substituted or unsubstituted C 6 ~ C 60 of the aryloxy group, a substituted or unsubstituted C 1 ~ C 40 alkyl silyl group, a substituted or unsubstituted C 6 ~ C 60 of the group, or a substituted Or an unsubstituted C 6 to C 60 arylamine group,
이때 상기 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기 및 아릴아민기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3~40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5~60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되되, 복수개의 치환기는 각각 동일하거나 상이할 수 있다.At this time, one or more substituents respectively introduced into the alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group and arylamine group are each independently selected from deuterium , A cyano group, a C 1 to C 40 alkyl group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms Group, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, and a C 6 to C 60 arylamine group, and the plurality of substituents may be the same or different.
또한, 본 발명은 (i) 양극, (ii) 음극, 및 (iii) 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중에서 적어도 하나는 상기 화합물을 포함하는 것이 특징인 유기 전계 발광 소자를 제공한다.The present invention also provides an organic electroluminescent device comprising (i) an anode, (ii) a cathode, and (iii) one or more organic layers sandwiched between the anode and the cathode, wherein at least one One of them is an organic electroluminescent device comprising the above compound.
여기서, 상기 화합물을 포함하는 유기물층은 정공 주입층, 정공 수송층 및 발광층으로 이루어진 군에서 선택되는 하나 이상인 것이 바람직하며, 특히 발광층의 인광 호스트 또는 형광 도펀트인 것이 더욱 바람직하다.Here, the organic compound layer containing the compound is preferably at least one selected from the group consisting of a hole injection layer, a hole transport layer and a light emitting layer, and more preferably a phosphorescent host or a fluorescent dopant of the light emitting layer.
본 발명의 화학식 1로 표시되는 화합물은 내열성, 정공 주입 및 수송 성능, 발광 성능이 우수하기 때문에, 유기 전계 발광 소자의 정공 주입층, 정공 수송층, 발광층의 인광/형광 호스트, 도판트 중 하나 이상에 적용할 수 있다.The compound represented by the general formula (1) of the present invention is excellent in heat resistance, hole injection and transportation performance, and light emitting performance. Therefore, it is preferable that the compound represented by the general formula (1) has at least one of phosphorescent / fluorescent host and dopant of the hole injection layer, Can be applied.
따라서, 본 발명의 신규 화합물을 사용하는 경우, 우수한 발광성능, 낮은 구동전압, 높은 전류효율 및 장수명을 갖는 유기 전계 발광소자를 제조할 수 있고, 나아가 성능, 수명이 크게 향상된 풀 칼라 디스플레이 패널도 제조할 수 있다. Accordingly, when the novel compound of the present invention is used, an organic electroluminescent device having excellent light emitting performance, low driving voltage, high current efficiency, and long life can be manufactured, and a full color display panel can do.
이하, 본 발명에 대하여 설명한다.Hereinafter, the present invention will be described.
본 발명에서는 종래 유기 EL 소자용 재료 [예: 4,4-dicarbazolybiphenyl (이하, 'CBP'로 표시함)]보다 높은 분자량을 가지면서, 넓은 에너지 밴드캡을 갖는 상기 화학식 1로 표시되는 화합물을 제공하는 것을 특징으로 한다. 상기 화합물을 유기 EL 소자에 이용할 경우, 소자의 구동 전압 및 효율 측면이 향상될 수 있다.The present invention provides a compound represented by the above formula (1) having a higher molecular weight than a conventional organic EL device material (for example, 4,4-dicarbazolybiphenyl (hereinafter referred to as "CBP" . When the above compound is used in an organic EL device, driving voltage and efficiency aspects of the device can be improved.
상기 화학식 1로 표시되는 화합물은, 나프탈렌의 양 말단에 인돌 골격이 융합(fused)되어 있고, 여러 치환체에 의해 에너지 레벨이 조절됨으로써, 넓은 밴드갭 (sky blue ~ red)을 갖게 된다. 이로 인해, 소자의 인광특성을 개선함과 동시에 정공 주입 능력 및/또는 수송 능력, 발광효율, 구동전압, 수명 특성 등이 개선될 수 있다. 따라서, 발광층뿐만 아니라, 여러 치환체의 도입으로 정공 수송층, 정공 주입층, 호스트 등으로 응용될 수 있다. 특히, 상기 화합물은 인돌계 기본골격으로 인해 넓은 밴드갭을 갖기 때문에, 종래 CBP에 비해 발광 호스트 재료로서의 우수한 특성을 나타낼 수 있다. The compound represented by Formula 1 has fused indole skeletons at both terminals of naphthalene and has a wide band gap (sky blue to red) by controlling the energy level by various substituents. Thus, the phosphorescent characteristics of the device can be improved, and the hole injecting ability and / or transporting ability, luminous efficiency, driving voltage, lifetime characteristics and the like can be improved. Therefore, it can be applied not only as a light emitting layer but also as a hole transporting layer, a hole injecting layer, a host, etc. by the introduction of various substituents. In particular, since the compound has a wide band gap due to the indole based basic skeleton, it can exhibit excellent characteristics as a light emitting host material compared to conventional CBP.
또한, 인돌계 기본골격에, 다수 도입된 다양한 방향족 환(aromatic ring) 치환체로 인해 화합물의 분자량이 유의적으로 증대됨으로써, 유리전이온도가 향상되고, 이로 인해 종래 CBP 보다 높은 열적 안정성을 가질 수 있다. 따라서, 본 발명의 화합물을 포함하는 소자는 내구성 및 수명 특성을 크게 향상시킬 수 있다. In addition, the molecular weight of the compound is significantly increased due to various aromatic ring substituents introduced into the indole-based basic skeleton, whereby the glass transition temperature is improved, and thus it can have higher thermal stability than the conventional CBP . Thus, devices comprising the compounds of the present invention can significantly improve durability and lifetime characteristics.
아울러, 상기 화합물을 유기 EL 소자의 정공 주입/수송층, 청색, 녹색 및/또는 적색의 인광 호스트 재료 또는 형광 도펀트 재료로 채택할 경우, CBP 대비 효율 및 수명 면에서 월등히 우수한 효과를 발휘할 수 있다. 따라서, 본 발명에 따른 화학식 1로 표시되는 화합물은 유기 EL 소자의 성능 개선 및 수명 향상에 크게 기여할 수 있으며, 특히 이러한 소자 수명 향상은 풀 칼라 유기 발광 패널에서의 성능 극대화에도 큰 효과가 있다.In addition, when the compound is used as a positive hole injection / transport layer, a blue, green and / or red phosphorescent host material or a fluorescent dopant material of an organic EL device, it can exert an excellent effect in terms of efficiency and lifetime compared to CBP. Accordingly, the compound represented by the formula (1) according to the present invention can greatly contribute to the improvement of the performance and lifetime of the organic EL device, and particularly the lifetime improvement of the device has a great effect in maximizing the performance in the full color organic light emitting panel.
상기 화학식 1로 표시되는 화합물에 있어서, A 및 B는 각각 치환 또는 비치환된 6-원(membered)의 환(cycle)으로서, 이들은 서로 단순 부착(pendant)되거나 축합(fused)되어 치환 또는 비치환된 나프탈렌 유도체를 형성한다. In the compound represented by Formula 1, A and B are each a substituted or unsubstituted 6-membered cycle, which are pendant or fused to each other to form a substituted or unsubstituted ring, To form a naphthalene derivative.
상기 나프탈렌 유도체는 중수소, 할로겐, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C60의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C6~C60의 아릴실릴기 및 치환 또는 비치환된 C6~C60의 아릴아민기로 구성된 군에서 선택된 치환기로 치환될 수 있으며, 이때 상기 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기 및 아릴아민기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3~40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5~60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되되, 복수개의 치환기는 각각 동일하거나 상이할 수 있다.The naphthalene derivative may be substituted with at least one selected from the group consisting of deuterium, halogen, substituted or unsubstituted C 1 to C 40 alkyl group, substituted or unsubstituted C 3 to C 40 cycloalkyl group, substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms , A substituted or unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 ring atoms, a substituted or unsubstituted C 1 to C 40 alkyloxy group, a C 6 ~ C 60 of the aryloxy group, a substituted or unsubstituted C 1 ~ C 40 alkyl silyl group, a substituted or unsubstituted C 6 ~ C 60 aryl silyl group, and a substituted or unsubstituted C 6 ~ C An aryl group, an aryloxy group, an aryloxy group, an aryloxy group, an aryloxy group, an aryloxy group, an aryloxy group, an aryloxy group, an aryloxy group, and an arylamine group having a carbon number of 1 to 60 , The one or more substituents introduced into the arylamine group, respectively, A halogen atom, a cyano group, a C 1 to C 40 alkyl group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, A heteroaryl group having 1 to 60 carbon atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, and a C 6 to C 60 arylamine group, with the plurality of substituents being the same or different Can be different.
상기 화학식 1로 표시되는 화합물에 있어서, Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5~60의 헤테로아릴기, 또는 치환 또는 비치환된 C6~C60의 아릴아민기인 것이 바람직하다. 이때, 상기 아릴기, 헤테로아릴기 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3~40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5~60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되되, 복수개의 치환기는 각각 동일하거나 상이할 수 있다.In the compound represented by Formula 1, Ar 1 and Ar 2 are each independently a substituted or unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 ring atoms, A substituted or unsubstituted C 6 to C 60 arylamine group. The aryl group, heteroaryl group and arylamine group are each independently selected from the group consisting of deuterium, a halogen, a cyano group, a C 1 to C 40 alkyl group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms , A C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, and a C 6 to C 60 arylamine group And a plurality of substituents may be the same or different.
보다 바람직하게는, Ar1 및 Ar2이 각각 독립적으로, 치환 또는 비치환된 페닐기, 치환 또는 비치환된 나프틸기(naphthyl group), 치환 또는 비치환된 피리딜기, 치환 또는 비치환된 피리미딘일기(pyrimidinyl group), 치환 또는 비치환된 트리아진일기(triazinyl group), 치환 또는 비치환된 퀴놀릴기(quinolyl group), 또는 치환 또는 비치환된 인돌릴기(indolyl group)기일 수 있고, 상기 페닐기, 나프틸기, 피리딜기, 피리리딘일기, 트리아진일기, 퀴놀릴기, 인돌릴기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3~40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5~60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되되, 복수개의 치환기는 각각 동일하거나 상이할 수 있다.More preferably, Ar 1 and Ar 2 each independently represent a substituted or unsubstituted phenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted pyrimidinyl group a pyrimidinyl group, a substituted or unsubstituted triazinyl group, a substituted or unsubstituted quinolyl group, or a substituted or unsubstituted indolyl group, and the phenyl group, A halogen atom, a cyano group, a C 1 to C 40 alkyl group, a C 3 to C 40 alkyl group, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted aryl group, 40 cycloalkyl group, the nuclear atoms 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 of the heteroaryl group, C 1 ~ alkyloxy group of C 40, C 6 ~ C 60 aryloxy, and C 6 ~ selected from the group consisting of C 60 arylamine A plurality of substituents may be the same or different.
더욱 바람직하게는, Ar1 및 Ar2이 각각 독립적으로 하기 치환기 S1 내지 치환기 S138로 이루어진 군에서 선택될 수 있다.More preferably, Ar < 1 > and Ar < 2 > each independently may be selected from the group consisting of Substituent S1 to Substituent S138.
본 발명에 따른 화학식 1로 표시되는 화합물의 예로는 하기 화학식 2로 표시되는 화합물 내지 화학식 8로 표시되는 화합물 등이 있는데, 이에 제한되지 않는다.Examples of the compound represented by the formula (1) according to the present invention include compounds represented by the following formulas (2) to (8), but are not limited thereto.
상기 화학식 2 내지 8에서, In the above Chemical Formulas 2 to 8,
Ar1과 Ar2, R1 내지 R8은 각각 화학식 1에서 정의된 바와 같고, Ar 1 and Ar 2, R 1 to R 8 are each as defined in formula (1)
R9 내지 R12는 각각 독립적으로 수소, 중수소, 할로겐, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C6~C60의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 60의 헤테로아릴기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C60의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C6~C60의 아릴실릴기, 또는 치환 또는 비치환된 C6~C60의 아릴아민기이고,R 9 to R 12 each independently represent hydrogen, deuterium, halogen, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 3 to C 40 cycloalkyl group, a substituted or unsubstituted nucleus atom number A substituted or unsubstituted C 6 to C 60 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 60 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkyl aryloxy group, arylsilyl a substituted or unsubstituted C 6 ~ C 60 of the aryloxy group, a substituted or unsubstituted C 1 ~ C 40 alkyl silyl group, a substituted or unsubstituted C 6 ~ C 60 of the group, or a substituted Or an unsubstituted C 6 to C 60 arylamine group,
이때 상기 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기 및 아릴아민기에 각각 도입되는 하나 이상의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노기,C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3~40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5~60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되되, 복수개의 치환기는 각각 동일하거나 상이할 수 있다. At this time, one or more substituents respectively introduced into the alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group and arylamine group are each independently selected from deuterium , A cyano group, a C 1 to C 40 alkyl group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms Group, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, and a C 6 to C 60 arylamine group, and the plurality of substituents may be the same or different.
하기 화학식들은 본 발명의 화학식 1의 화합물의 대표적인 예들이나, 본 발명의 화학식 1의 화합물이 하기 예시된 것들에 한정되는 것은 아니다.The following formulas are typical examples of the compound of formula (I) of the present invention, but the compound of formula (I) of the present invention is not limited to those exemplified below.
본 발명에서 사용된 "비치환된 알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소이며, 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 포함한다. "Unsubstituted alkyl" used in the present invention is a linear or branched saturated hydrocarbon having 1 to 40 carbon atoms, and examples thereof include methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, .
"비치환된 시클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소 그룹을 포함한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 놀보닐(norbornyl), 아다만틴(adamantine)등이 포함되지만 이에 한정되는 것은 아니다. "Unsubstituted cycloalkyl" includes monocyclic or polycyclic non-aromatic hydrocarbon groups of 3 to 40 carbon atoms. Examples of such cycloalkyls include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
"비치환된 헤테로시클로알킬"은 핵원자수 3 내지 40의 비-방향족 부위를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로 원자로 치환된다. 이의 비-제한적인 예로는 모르폴린, 피페라진 등이 있다."Unsubstituted heterocycloalkyl" means a non-aromatic moiety of 3 to 40 nucleus atoms in which at least one of the carbons, preferably one to three carbons, is replaced with a heteroatom such as N, O or S . Non-limiting examples thereof include morpholine, piperazine, and the like.
"비치환된 아릴"은 단독 고리 혹은 2 이상의 고리가 조합된, 탄소수 6 내지 60의 방향족 부위를 의미한다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된(fused) 형태로 부착될 수 있다. 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등이 포함되며 이에 한정되는 것은 아니다. "Unsubstituted aryl" means an aromatic moiety having from 6 to 60 carbon atoms, either a single ring or a combination of two or more rings. Two or more rings may be attached to each other in a pendant or fused form to each other. Examples of aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.
"비치환된 헤테로아릴"은 핵원자수 5 내지 60의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 부위를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된(fused) 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함하는 것으로 해석한다. 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리를 포함하고, 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등도 포함하는 것으로 해석한다."Unsubstituted heteroaryl" means a monoheterocyclic or polyheterocyclic aromatic moiety of 5 to 60 nucleus atoms in which at least one carbon, preferably one to three carbons, of the ring is replaced by N, O, S Or < RTI ID = 0.0 > Se. ≪ / RTI > It is interpreted that two or more rings may be attached to each other in a pendant or fused form to each other and further include a condensed form with an aryl group. Examples of heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl; Such as phenoxathienyl, indolizinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl, and the like. Includes rings and is also meant to include 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl and the like.
"비치환된 알킬옥시"는 1 내지 40개의 탄소 원자가 산소와 부착된 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함하는 것으로 해석한다. 알킬옥시기의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등이 포함될 수 있으며 이에 한정되지는 않는다. "Unsubstituted alkyloxy" means alkyl having from 1 to 40 carbon atoms attached to oxygen and is understood to include linear, branched or cyclic structures. Examples of alkyloxy groups include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
"비치환된 아릴옥시"는 탄소수 5 내지 60의 페닐옥시, 나프틸옥시, 디페닐옥시 등을 포함하고, "비치환된 아릴아민"은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다."Unsubstituted aryloxy" includes phenyloxy, naphthyloxy, diphenyloxy and the like having 5 to 60 carbon atoms, and "unsubstituted arylamine" means an amine substituted with aryl having 6 to 60 carbon atoms.
"축합(fused) 고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다."Fused ring" means a fused aliphatic ring, a fused aromatic ring, a fused heteroaliphatic ring, a fused heteroaromatic ring, or a combination thereof.
본 발명의 화학식 1의 화합물은 일반적인 합성방법에 따라 합성될 수 있다(Chem. Rev., 60:313 (1960); J. Chem. SOC. 4482 (1955); Chem. Rev. 95: 2457 (1995) 등 참조). 본 발명의 화합물에 대한 상세한 합성 과정은 후술하는 합성예에서 구체적으로 기술하도록 한다. The compounds of formula 1 of the present invention can be synthesized according to the general synthetic methods ( Chem. Rev. , 60 : 313 (1960); J. Chem. SOC . 4482 (1955); Chem. Rev. 95: 2457 (1995 ). Detailed synthesis of the compound of the present invention will be described in detail in Synthesis Examples to be described later.
한편, 본 발명은 전술한 화학식 1로 표시되는 화합물, 바람직하게는 화학식 2 내지 화학식 8로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.Meanwhile, the present invention provides an organic electroluminescent device comprising a compound represented by the above-mentioned formula (1), preferably a compound represented by the following formulas (2) to (8).
구체적으로, 본 발명은 양극(anode); 음극(cathode); 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 EL 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물, 바람직하게는 화학식 2 내지 화학식 8로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 EL 소자를 제공한다. 이때, 상기 화학식 1 내지 8의 화합물은 단독 또는 복수로 포함될 수 있다. Specifically, the present invention provides a fuel cell comprising: an anode; A cathode; And at least one organic material layer interposed between the anode and the cathode, wherein at least one of the one or more organic material layers is a compound represented by the formula (1), preferably a compound represented by the following formula And a compound represented by the formula (1). At this time, the compounds of the formulas (1) to (8) may be included singly or in plurality.
본 발명의 화학식 1로 표시되는 화합물, 바람직하게는 화학식 2 내지 화학식 8로 표시되는 화합물을 포함하는 유기물 층은 정공 주입층, 정공 수송층, 및 발광층 중 어느 하나 이상일 수 있다. 바람직하게는 정공 주입층, 정공 수송층의 재료로서 유기 EL 소자에 포함될 수 있다. 이 경우 유기 EL 소자는 정공 주입/수송 능력을 극대화할 수 있다. 또한, 유기 EL 소자의 발광층 재료, 바람직하게는 청색, 녹색 및/또는 인광 호스트, 형광 도펀트로 사용됨으로써, 향상된 효율 및 수명을 제공할 수 있다. The organic compound layer containing the compound represented by the formula (1) of the present invention, preferably the compound represented by the formulas (2) to (8) may be any one or more of a hole injecting layer, a hole transporting layer and a light emitting layer. And may be included in the organic EL device as the material of the hole injection layer and the hole transport layer. In this case, the organic EL device can maximize the hole injection / transport capability. Further, it can be used as a light emitting layer material of an organic EL device, preferably a blue, green and / or phosphorescent host, and a fluorescent dopant, thereby providing improved efficiency and lifetime.
또한, 본 발명에 따른 화학식 1, 바람직하게는 화학식 2 내지 화학식 8로 표시되는 화합물은 높은 유리 전이 온도를 가지고 있다. 따라서, 상기 화합물을 유기 발광 소자의 유기물 층으로 사용할 경우, 유기 발광 소자 내에서 결정화가 일어나는 것이 최소화되기 때문에, 소자의 구동전압을 낮출 수 있고, 발광효율, 열적 안정성 및 수명 특성을 향상시킬 수 있다.In addition, the compound represented by Formula 1 according to the present invention, preferably Formula 2 to Formula 8, has a high glass transition temperature. Therefore, when the compound is used as the organic material layer of the organic light emitting device, the crystallization in the organic light emitting device is minimized, so the driving voltage of the device can be lowered and the light emitting efficiency, thermal stability and lifetime characteristics can be improved .
본 발명에 따른 유기 EL 소자 구조의 비제한적인 예를 들면, 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극이 순차적으로 적층된 것일 수 있다. 이때, 상기 정공 주입층, 정공 수송층 및 발광층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 또한, 본 발명의 화합물은 발광층의 인광 호스트 또는 형광 도펀트로 이용될 수 있다. 상기 전자 수송층 위에는 전자 주입층이 위치할 수도 있다.Non-limiting examples of the structure of the organic EL device according to the present invention may include a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode sequentially laminated. At least one of the hole injecting layer, the hole transporting layer, and the light emitting layer may include the compound represented by the above formula (1). Further, the compound of the present invention can be used as a phosphorescent host or a fluorescent dopant of the light emitting layer. An electron injection layer may be disposed on the electron transport layer.
또한, 본 발명에 따른 유기 EL 소자는 전술한 바와 같이 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층된 구조뿐만 아니라, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입될 수 있다. In addition, the organic EL device according to the present invention may have an insulating layer or an adhesive layer inserted into the interface between the electrode and the organic layer as well as the structure in which the anode, one or more organic layers and the cathode are sequentially stacked, as described above.
본 발명에 따른 유기 EL 소자에 있어서, 상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 진공증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에만 한정되지 않는다. In the organic EL device according to the present invention, the organic material layer containing the compound represented by Formula 1 may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
본 발명에 따른 유기 EL 소자는 유기물층 중 1층 이상을 본 발명의 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는, 당 기술 분야에 알려져 있는 재료 및 방법을 이용하여 유기물층 및 전극을 형성하여 제조될 수 있다.The organic EL device according to the present invention may be formed by using materials and methods known in the art, except that at least one layer of the organic material layer is formed so as to contain the compound represented by the formula (1) of the present invention .
예컨대, 기판으로는 실리콘 웨이퍼, 석영 또는 유리판, 금속판, 플라스틱 필름이나 시트 등이 사용될 수 있다. For example, a silicon wafer, quartz or glass plate, a metal plate, a plastic film or a sheet can be used as the substrate.
양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자; 또는 카본블랙 등이 있으나, 이들에만 한정되는 것은 아니다. Examples of the positive electrode material include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole and polyaniline; Or carbon black, but are not limited thereto.
음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다. Examples of the negative electrode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin or lead or alloys thereof; Layer structure materials such as LiF / Al or LiO 2 / Al, but are not limited thereto.
또한, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당업계에 알려진 통상의 물질이 사용될 수 있다.
The electron injecting layer and the electron transporting layer are not particularly limited, and ordinary materials known in the art can be used.
이하, 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명이 하기 실시예에 의해 한정되는 것은 아니다. Hereinafter, the present invention will be described in detail with reference to the following examples. However, the following examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
[준비예 1] 1,8-dihydrocarbazolo[4,3-c]carbazole의 합성[Preparation Example 1] Synthesis of 1,8-dihydrocarbazolo [4,3-c] carbazole
<준비단계 1-1> 1,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naph thalene의 합성<Preparation Step 1-1> Synthesis of 1,5-bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene
질소 기류 하에서 1,5-dibromonaphthalene (30g, 0.105mol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (80 g, 0.315mol), 팔라듐비스디페닐포스피노페로센디클로로(Pd(dppf)Cl2)(8.57 g, 10 mol%), 포타슘아세테이트(KOAc)(61.78 g, 0.63 mol%), 및 N,N-디메틸포름아미드(N,N-dimethylformamide, DMF)(1000 ml)를 혼합하고 130 ℃에서 12시간 동안 교반하였다.1,5-dibromonaphthalene (30 g, 0.105 mol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'- dioxaborolane (80 g, 0.315 mol), palladium bisdiphenylphosphinoferrocene dichloro (Pd (dppf) Cl 2 ) (8.57 g, 10 mol%), potassium acetate (KOAc) (61.78 g, 0.63 mol% N, N-dimethylformamide (DMF) (1000 ml) were mixed and stirred at 130 ° C for 12 hours.
반응 종결 후, 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 5:1 (v/v))로 정제하여, 1,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene (22.1 g, 수율 55 %)을 얻었다. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, and the residue was purified by column chromatography (Hexane: EA = 5: 1 (v / v)) to remove moisture with MgSO 4 . , 5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene (22.1 g, yield 55%).
1H-NMR: δ 1.42 (s, 24H), 7.51 (t, 2H), 8.06 (d, 2H), 8.88 (d, 2H) 1 H-NMR: δ 1.42 ( s, 24H), 7.51 (t, 2H), 8.06 (d, 2H), 8.88 (d, 2H)
<준비단계 1-2> 1,5-<Preparation step 1-2> 1,5- bisbis (2-(2- nitrophenylnitrophenyl )naphthalene의 합성) Synthesis of naphthalene
질소 기류 하에서, 1-bromo-2-nitrobenzene (23.31 g, 115.37 mmol), 상기 <준비단계 1-1>에서 얻은 1,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene (20 g, 54.94 mmol), NaOH (13.19 g, 329.63 mmol) 및 Toluene/H2O (200 ml/100 ml)를 혼합한 다음, 40 ℃에서 팔라듐테드라키스트리페닐포스핀(Pd(PPh3)4)(6.34 g, 10 mol%)를 넣은 후, 혼합물을 120 ℃에서 12시간 동안 교반하였다.1-bromo-2-nitrobenzene (23.31 g, 115.37 mmol) and 1,5-bis (4,4,5,5-tetramethyl-1,3,2 -dioxaborolan-2-yl) naphthalene (20 g, 54.94 mmol), NaOH (13.19 g, 329.63 mmol) and Toluene / H 2 O (200 ml / 100 ml) were mixed and then palladium- insert the phosphine (Pd (PPh 3) 4) (6.34 g, 10 mol%), the mixture was stirred at 120 ℃ for 12 hours.
반응 종결 후, 반응 온도를 상온으로 냉각시켜 고체 생성물을 얻은 다음, 고체 생성물을 필터링하였다. 이후, 필터링된 고체 생성물을 디클로로메탄과 아세톤으로 재결정하여, 노란색 고체인 1,5-bis(2-nitrophenyl)naphthalene (12.41 g, 수율 61 %)을 얻었다. After completion of the reaction, the reaction temperature was cooled to room temperature to obtain a solid product, and then the solid product was filtered. Subsequently, the filtered solid product was recrystallized from dichloromethane and acetone to obtain 1.5-bis (2-nitrophenyl) naphthalene (12.41 g, yield 61%) as a yellow solid.
1H-NMR: δ 7.52 (t, 2H), 7.62 (t, 2H), 7.89 (t, 2H), 8.05 (d, 2H), 8.12 (d, 2H), 8.32 (d, 2H), 8.53 (d, 2H) 1 H-NMR: δ 7.52 ( t, 2H), 7.62 (t, 2H), 7.89 (t, 2H), 8.05 (d, 2H), 8.12 (d, 2H), 8.32 (d, 2H), 8.53 ( d, 2H)
<준비단계 1-3> 1,8-≪ Preparation step 1-3 > dihydrocarbazolodihydrocarbazolo [4,3-c]carbazole의 합성[4,3-c] carbazole
질소 기류 하에서, 상기 <준비단계 1-2>에서 얻은 1,5-bis(2-nitrophenyl)naphthalene (10g, 27 mmol)을, triphenylphosphine (35.41 g, 135 mmol) 및 o-dichlorobenzene (100 ml)과 혼합한 후, 이들을 12 시간 동안 교반하였다.Bis (2-nitrophenyl) naphthalene (10 g, 27 mmol) obtained in <preparation step 1-2> was dissolved in triphenylphosphine (35.41 g, 135 mmol) and o- dichlorobenzene After mixing, they were stirred for 12 hours.
반응 종료 후, o-dichlorobenzene를 제거하고, 디클로로메탄으로 추출하여 유기층을 얻었다. 이후, 얻은 유기층에서 MgSO4를 이용하여 물을 제거한 후 컬럼크로마토그래피 (Hexane:EA=3:1 (v/v))로 정제하여, 1,8-dihydrocarbazolo[4,3-c]carbazole (3.56 g, 수율 43 %)을 얻었다. After completion of the reaction, o-dichlorobenzene was removed, and the organic layer was extracted with dichloromethane. Then, water was removed from the obtained organic layer using MgSO 4 and purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 1,8-dihydrocarbazolo [4,3- g, yield: 43%).
1H-NMR: δ 7.53 (d, 2H), 7.64 (t, 2H), 8.08 (t, 2H), 8.14 (d, 2H), 8.33 (d, 2H), 8.54 (d, 2H), 8.75 (s, 2H)
1 H-NMR: δ 7.53 ( d, 2H), 7.64 (t, 2H), 8.08 (t, 2H), 8.14 (d, 2H), 8.33 (d, 2H), 8.54 (d, 2H), 8.75 ( s, 2H)
[준비예 2] 4,11-diphenyl-1,8-dihydrocarbazolo[4,3-c]carbazole의 합성[Preparation Example 2] Synthesis of 4,11-diphenyl-1,8-dihydrocarbazolo [4,3-c] carbazole
<준비단계 2-1> 1,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naph thalene의 합성<Preparation Step 2-1> Synthesis of 1,5-bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene
준비예 1의 준비단계 1-1과 동일하게 수행하여 1,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene (22.1 g, 수율 55 %)을 얻었다. (22.1 g, yield 55%) of 1,5-bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene was obtained in the same manner as in the preparation step 1-1 of Preparation Example 1, ).
<준비단계 2-2> 1,5-<Preparation step 2-2> 1,5- bisbis (5-(5- bromobromo -2--2- nitrophenylnitrophenyl )naphthalene 의 합성) Synthesis of naphthalene
준비예 1의 준비단계 1-2에서 사용된 1-bromo-2-nitrobenzene 대신 2,4-dibromo-1-nitrobenzene(15.52 g, 55.25 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <준비단계 1-2>와 동일하게 수행하여 1,5-bis(5-bromo-2-nitrophenyl)naphthalene (6.53 g, 수율 47 %)을 얻었다.Except that 2,4-dibromo-1-nitrobenzene (15.52 g, 55.25 mmol) was used in place of 1-bromo-2-nitrobenzene used in Preparation Step 1-2 of Preparation Example 1, 1,5-bis (5-bromo-2-nitrophenyl) naphthalene (6.53 g, yield 47%) was obtained in the same manner as in preparation step 1-2.
1H NMR: δ 7.56 (t, 2H), 7.84 (d, 2H), 8.01 (d, 2H), 8.36 (d, 2H), 8.57 (d, 2H), 8.61 (s, 2H) 1 H NMR: δ 7.56 (t , 2H), 7.84 (d, 2H), 8.01 (d, 2H), 8.36 (d, 2H), 8.57 (d, 2H), 8.61 (s, 2H)
<준비단계 2-3> 4,11-<Preparation step 2-3> 4, 11- dibromodibromo -1,8--1,8- dihydrocarbazolodihydrocarbazolo [4,3-c]carbazole의 합성[4,3-c] carbazole
준비예 1의 준비단계 1-3에서 사용된 1,5-bis(2-nitrophenyl)naphthalene 대신 상기 <준비단계 2-2>에서 얻은 1,5-bis(5-bromo-2-nitrophenyl)naphthalene(10 g, 18.93 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <준비단계 1-3>과 동일하게 수행하여 4,11-dibromo-1,8-dihydrocarbazolo[4,3-c]carbazole (3.43 g, 수율 39 %)을 얻었다.Preparation of Preparation Example 1 The procedure of Preparation Example 1 was repeated except that 1,5-bis (5-bromo-2-nitrophenyl) naphthalene (prepared in Preparation Example 2-2) Dibromo-1,8-dihydrocarbazolo [4,3-c] carbazole (prepared according to Preparation Example 1) was used in place of 3.43 g, yield 39%).
1H NMR: δ 7.57 (d, 2H), 8.02 (d, 2H), 8.35 (d, 2H), 8.56 (d, 2H), 8.61 (s, 2H), 8.77 (s, 2H) 1 H NMR: δ 7.57 (d , 2H), 8.02 (d, 2H), 8.35 (d, 2H), 8.56 (d, 2H), 8.61 (s, 2H), 8.77 (s, 2H)
<준비단계 2-4> 4,11-diphenyl-1,8-dihydrocarbazolo[4,3-c]carbazole의 합성<Preparation Step 2-4> Synthesis of 4,11-diphenyl-1,8-dihydrocarbazolo [4,3-c] carbazole
상기 준비예 2의 <준비단계 1-2>에서 사용된 1-bromo-2-nitrobenzene(23.31 g, 115.37 mmol) 대신 phenylboronic acid (1.65 g, 13.57 mmol)을 사용하고, 1,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene (20 g, 54.94 mmol) 대신 상기 준비예 2의 <준비단계 2-3>에서 얻은 4,11-dibromo-1,8-dihydrocarbazolo[4,3-c]carbazole (3 g, 6.46 mmol)을 사용하며, toluene 대신 THF를 사용하는 것을 제외하고는, 상기 준비예 2의 <준비단계 1-2>와 동일하게 수행하여 교반하였다.Phenylboronic acid (1.65 g, 13.57 mmol) was used instead of 1-bromo-2-nitrobenzene (23.31 g, 115.37 mmol) used in Preparation Example 1-2 of Preparation Example 2, Prepared in Preparation Example 2, instead of 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene (20 g, 54.94 mmol) Preparation step 1-2 of Preparation Example 2 was repeated except that 1,8-dihydrocarbazolo [4,3-c] carbazole (3 g, 6.46 mmol) was used and THF was used instead of toluene Followed by stirring.
반응이 종결된 후, 디클로로메탄으로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:MC = 1:1 (v/v))로 정제하여 4,11-diphenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (2.31 g, 수율 78 %)을 얻었다. After completion of the reaction, the reaction mixture was extracted with dichloromethane, and the residue was purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to remove moisture with MgSO 4 . dihydrocarbazolo [4,3-c] carbazole (2.31 g, yield 78%).
1H-NMR: δ 7.59 (d, 2H), 7.64 (m, 6H), 7.71(m, 4H), 8.05 (d, 2H), 8.12 (d, 2H), 8.33 (d, 2H), 8.54 (s, 2H), 8.78 (s, 2H)
1 H-NMR: δ 7.59 ( d, 2H), 7.64 (m, 6H), 7.71 (m, 4H), 8.05 (d, 2H), 8.12 (d, 2H), 8.33 (d, 2H), 8.54 ( s, 2 H), 8.78 (s, 2 H)
[준비예 3] 13,14-dihydrocarbazolo[1,2-a]carbazole 및 1,4-dihydrocarbazolo[2,3-b]carbazole 의 합성Preparation Example 3 Synthesis of 13,14-dihydrocarbazolo [1,2-a] carbazole and 1,4-dihydrocarbazolo [2,3-b] carbazole
<준비단계 3-1> 2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphtha <Preparation Step 3-1> Preparation of 2,7-bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphtha alenealene 의 합성Synthesis of
준비예 1의 <준비단계 1-1>에서 사용된 1,5-dibromonaphthalene 대신 2,7-dibromonaphthalene (30 g, 104.91 mmol)를 사용하는 것을 제외하고는, 상기 준비예 1의 <준비단계 1-1>과 동일하게 수행하여 2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphtha alene (22.33 g, 수율 56 %)을 얻었다.Preparation step 1-Preparation of Preparation Example 1 The procedure of Preparation Example 1 was repeated, except that 2,7-dibromonaphthalene (30 g, 104.91 mmol) was used instead of 1,5-dibromonaphthalene used in <preparation step 1-1> 1>, 2,7-bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphtha alene (22.33 g, yield 56%) was obtained.
1H-NMR: δ 1.43 (s, 24H), 7.57 (d, 2H), 8.53 (d, 2H), 8.86 (s, 2H) 1 H-NMR: δ 1.43 ( s, 24H), 7.57 (d, 2H), 8.53 (d, 2H), 8.86 (s, 2H)
<준비단계 3-2> 2,7-≪ Preparation step 3-2 > bisbis (2-(2- nitrophenylnitrophenyl )naphthalene의 합성) Synthesis of naphthalene
준비예 1의 <준비단계 1-2>에서 사용된 1,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene 대신 상기 <준비단계 3-1>에서 얻은 2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene (20 g, 52.63 mmol)를 사용하고, toluene 대신 THF를 사용하는 것을 제외하고는, 상기 준비예 1의 <준비단계 1-2>와 동일하게 수행하여 2,7-bis(2-nitrophenyl)naphthalene (11.5 g, 수율 59 %)을 얻었다.(Preparation Step 3-A) instead of 1,5-bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene used in <Preparation Step 1-2> (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene (20 g, 52.63 mmol) obtained in Example 1 and using THF instead of toluene 2,7-bis (2-nitrophenyl) naphthalene (11.5 g, yield 59%) was obtained in the same manner as in <Preparation step 1-2> of Preparation Example 1,
1H-NMR: δ 7.53 (d, 2H), 7.63 (t, 2H), 7.86 (t, 2H), 8.04 (d, 2H), 8.11 (d, 2H), 8.34 (s, 2H), 8.54 (d, 2H) 1 H-NMR: δ 7.53 ( d, 2H), 7.63 (t, 2H), 7.86 (t, 2H), 8.04 (d, 2H), 8.11 (d, 2H), 8.34 (s, 2H), 8.54 ( d, 2H)
<준비단계 3-3> 13,14-dihydrocarbazolo[1,2-a]carbazole과 1,4-dihydrocarbazolo [2,3-b]Preparation Step 3-3 Preparation of 13,14-dihydrocarbazolo [1,2-a] carbazole and 1,4-dihydrocarbazolo [2,3-b] carbazolecarbazole 의 합성Synthesis of
준비예 1의 <준비단계 1-3>에서 사용된 1,5-bis(2-nitrophenyl)naphthalene 대신 상기 <준비단계 3-2>에서 얻은 2,7-bis(2-nitrophenyl)naphthalene(10 g, 26.96 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <준비단계 1-3>과 동일하게 수행하여, 13,14-dihydrocarbazolo[1,2-a]carbazole (2.56 g, 수율 31 %)과 1,4-dihydrocarbazolo[2,3-b]carbazole (2.4 g, 수율 29 %)을 얻었다.(2-nitrophenyl) naphthalene (obtained in Preparation 3-2) instead of 1,5-bis (2-nitrophenyl) naphthalene used in Preparation Example 1-3 of Preparation Example 1 Dihydrocarbazolo [1,2-a] carbazole (2.56 g, yield: 31%) was obtained in the same manner as in <Preparation step 1-3> of Preparation Example 1, And 1,4-dihydrocarbazolo [2,3-b] carbazole (2.4 g, yield 29%).
13,14-dihydrocarbazolo[1,2-a]carbazole의 1H-NMR: δ 7.55 (d, 2H), 7.65 (t, 2H), 8.09 (t, 2H), 8.15 (d, 2H), 8.32 (d, 2H), 8.53 (d, 2H), 8.76 (s, 2H)13,14-dihydrocarbazolo [1,2-a] 1 the carbazole H-NMR: δ 7.55 ( d, 2H), 7.65 (t, 2H), 8.09 (t, 2H), 8.15 (d, 2H), 8.32 ( d, 2H), 8.53 (d, 2H), 8.76 (s, 2H)
1,4-dihydrocarbazolo[2,3-b]carbazole의 1H-NMR: δ 7.54 (s, 2H), 7.64 (t, 2H), 8.10 (t, 2H), 8.16 (s, 2H), 8.33 (d, 2H), 8.53 (d, 2H), 8.78 (s, 2H)
1,4-dihydrocarbazolo [2,3-b] 1 H-NMR of the carbazole: δ 7.54 (s, 2H ), 7.64 (t, 2H), 8.10 (t, 2H), 8.16 (s, 2H), 8.33 ( d, 2H), 8.53 (d, 2H), 8.78 (s, 2H)
[준비예 4] 5,12-dihydrocarbazolo[2,1-a]carbazole 및 5,12-dihydrocarbazolo [3,2-b]carbazole의 합성Preparation Example 4 Synthesis of 5,12-dihydrocarbazolo [2,1-a] carbazole and 5,12-dihydrocarbazolo [3,2-b] carbazole
<준비단계 4-1> 2,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene의 합성<Preparation Step 4-1> Synthesis of 2,6-bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene
준비예 1의 <준비단계 1-1>에서 사용된 1,5-dibromonaphthalene 대신 2,6-dibromonaphthalene(30 g, 104.89 mmol)을 사용하는 것을 제외하고는, 상기 준비예 1의 <준비단계 1-1>과 동일하게 수행하여 2,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene(21.13 g, 수율 53 %)을 얻었다.Preparation step 1-Preparation of Preparation Example 1 was repeated except that 2,6-dibromonaphthalene (30 g, 104.89 mmol) was used instead of 1,5-dibromonaphthalene used in <Preparation step 1-1> 1>, 2,6-bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene (21.13 g, yield 53%) was obtained.
1H-NMR: δ 1.44 (s, 24H), 7.56 (d, 2H), 8.61 (d, 2H), 8.85 (s, 2H) 1 H-NMR: δ 1.44 ( s, 24H), 7.56 (d, 2H), 8.61 (d, 2H), 8.85 (s, 2H)
<준비단계 4-2> 2,6-<Preparation step 4-2> The 2,6- bisbis (2-(2- nitrophenylnitrophenyl )naphthalene의 합성) Synthesis of naphthalene
준비예 1의 <준비단계 1-2>에서 사용된 1,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene 대신 2,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalene (20 g, 52.63 mmol)을 사용하고, toluene 대신 THF를 사용하는 것을 제외하고는 상기 준비예 1의 <준비단계 1-2>와 동일하게 수행하여 2,6-bis(2-nitrophenyl)naphthalene(12.28 g, 수율 63 %)을 얻었다.Bis (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene used in Preparation Example 1-2 of Preparation Example 1 was used instead of 2,6-bis Preparation Example 1 was repeated except that 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) naphthalene (20 g, 52.63 mmol) was used and THF was used instead of toluene. 2,2-bis (2-nitrophenyl) naphthalene (12.28 g, yield 63%) was obtained in the same manner as in Preparation step 1-2.
1H-NMR: δ 7.54 (d, 2H), 7.63 (t, 2H), 7.85 (t, 2H), 8.03 (d, 2H), 8.13 (d, 2H), 8.32 (s, 2H), 8.53 (d, 2H) 1 H-NMR: δ 7.54 ( d, 2H), 7.63 (t, 2H), 7.85 (t, 2H), 8.03 (d, 2H), 8.13 (d, 2H), 8.32 (s, 2H), 8.53 ( d, 2H)
<준비단계 4-3> 5,12-dihydrocarbazolo[2,1-a]carbazole과 5,12-dihydrocarbazolo [3,2-b]Preparation Step 4-3 Preparation of 5,12-dihydrocarbazolo [2,1-a] carbazole and 5,12-dihydrocarbazolo [3,2-b] carbazolecarbazole 의 합성Synthesis of
준비예 1의 <준비단계 1-3>에서 사용된 1,5-bis(2-nitrophenyl)naphthalene 대신 상기 <준비단계 4-2>에서 얻은 2,6-bis(2-nitrophenyl)naphthalene (10 g, 26.98 mmol)을 사용하는 것을 제외하고는, 준비예 1의 <준비단계 1-3>과 동일하게 수행하여 5,12-dihydrocarbazolo[2,1-a]carbazole (2.48 g, 수율 30 %)과 5,12-dihydrocarbazolo[3,2-b]carbazole (2.65 g, 수율 32 %)을 얻었다.(2-nitrophenyl) naphthalene (10 g) obtained in Preparation <Step 4-2> was used instead of 1,5-bis (2-nitrophenyl) naphthalene used in Preparation < , 26.98 mmol) was used in place of 5,12-dihydrocarbazolo [2,1-a] carbazole (2.48 g, yield 30%) and 5,12-dihydrocarbazolo [3,2-b] carbazole (2.65 g, yield 32%).
5,12-dihydrocarbazolo[2,1-a]carbazole의 1H-NMR: δ 7.54 (d, 2H), 7.66 (t, 2H), 8.08 (t, 2H), 8.14 (d, 2H), 8.33 (d, 2H), 8.52 (d, 2H), 8.77 (s, 2H)5,12-dihydrocarbazolo [2,1-a] 1 H-NMR of the carbazole: δ 7.54 (d, 2H ), 7.66 (t, 2H), 8.08 (t, 2H), 8.14 (d, 2H), 8.33 ( d, 2H), 8.52 (d, 2H), 8.77 (s, 2H)
5,12-dihydrocarbazolo[3,2-b]carbazole의 1H-NMR: δ 7.55 (s, 2H), 7.65 (t, 2H), 8.10 (t, 2H), 8.13 (s, 2H), 8.34 (d, 2H), 8.54 (d, 2H), 8.78 (s, 2H)
5,12-dihydrocarbazolo [3,2-b] carbazole in 1 H-NMR: δ 7.55 ( s, 2H), 7.65 (t, 2H), 8.10 (t, 2H), 8.13 (s, 2H), 8.34 ( d, 2H), 8.54 (d, 2H), 8.78 (s, 2H)
[[ 합성예Synthetic example 1] 화합물 1] Compound InvInv -1의 합성Synthesis of -1
<합성단계 1-1> 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole의 합성<Synthesis Step 1-1> Synthesis of 1-phenyl-1,8-dihydrocarbazolo [4,3-c] carbazole
질소 기류 하에서, 준비예 1에서 합성된 화합물 1,8-dihydrocarbazolo[4,3-c]carbazole (5 g, 16.32 mmol), iodobenzene (4.99 g, 24.48 mmol), Cu powder(0.1 g, 1.63 mmol), K2CO3(2.26 g, 16.32 mmol), Na2SO4(2.32 g, 16.32 mmol) 및 nitrobenzene(100 ml)를 혼합한 후, 190 ℃에서 12 시간 동안 교반하였다. 반응이 종결된 후, nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리한 다음, MgSO4를 사용하여 물을 제거하였다. 유기층의 용매를 제거한 후, 컬럼 크로마토그래피(Hexane:MC = 1:1 (v/v))로 정제하여 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (4.43 g, 수율 71 %)을 얻었다. Dihydrocarbazolo [4,3-c] carbazole (5 g, 16.32 mmol), iodobenzene (4.99 g, 24.48 mmol) and Cu powder (0.1 g, 1.63 mmol) in a nitrogen stream, , K 2 CO 3 (2.26 g, 16.32 mmol), Na 2 SO 4 (2.32 g, 16.32 mmol) and nitrobenzene (100 ml) were mixed and stirred at 190 ° C for 12 hours. After the reaction was terminated, the nitrobenzene was removed, the organic layer was separated with methylene chloride, and then the water was removed using MgSO 4 . The solvent of the organic layer was removed and the residue was purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to obtain 1.43 g of 1-phenyl-1,8- dihydrocarbazolo [4,3- %).
<합성단계 1-2> 화합물 Inv-1의 합성<Synthesis step 1-2> Synthesis of compound Inv-1
상기 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 상기 <합성단계 1-1>에서 합성된 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (4 g, 10.46 mmol)를 사용하고, iodobenzene (4.99 g, 24.48 mmol) 대신 2-bromo-4,6-diphenyl-1,3,5-triazine (4.9 g, 15.69 mmol)를 사용하는 것을 제외하고는, 상기 <합성단계 1-1>과 동일하게 수행하여 화합물 Inv-1 (4.04 g, 63 %)을 얻었다.1-phenyl-1,8-dihydrocarbazolo [4,3-c] pyridine synthesized in Synthesis Step 1-1 was used instead of 1,8-dihydrocarbazolo [4,3- 2-bromo-4,6-diphenyl-1,3,5-triazine (4.9 g, 15.69 mmol) was used instead of iodobenzene (4.99 g, 24.48 mmol) The compound Inv-1 (4.04 g, 63%) was obtained in the same manner as in the above <synthesis step 1-1>.
GC-Mass (이론치: 613.23 g/mol, 측정치: 613 g/mol)GC-Mass (theory: 613.23 g / mol, measured: 613 g / mol)
Elemental Analysis: C, 84.15; H, 4.43; N, 11.41
Elemental Analysis: C, 84.15; H, 4.43; N, 11.41
[[ 합성예Synthetic example 2] 화합물 2] Compound InvInv -2의 합성Synthesis of -2
<합성단계 2-1> 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole의 합성<Synthesis Step 2-1> Synthesis of 1-phenyl-1,8-dihydrocarbazolo [4,3-c] carbazole
상기 합성예 2의 <합성단계 1-1>과 동일하게 수행하여, 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (4.43 g, 수율 71 %)을 얻었다. 1-phenyl-1,8-dihydrocarbazolo [4,3-c] carbazole (4.43 g, yield 71%) was obtained in the same manner as in <Synthesis step 1-1> of Synthesis Example 2.
<합성단계 2-2> 화합물 Inv-2의 합성<Synthesis Step 2-2> Synthesis of Compound Inv-2
합성예 1의 <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 3-(3-bromophenyl)pyridine (2.76 g, 11.78 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-2>와 동일하게 수행하여, 화합물 Inv-2 (3.03 g, 수율 72 %)를 얻었다.3- (3-bromophenyl) pyridine (2.76 g, 11.78 mmol) was used instead of the 2-bromo-4,6-diphenyl-1,3,5-triazine used in Synthesis Step 1-2 in Synthesis Example 1 , The compound Inv-2 (3.03 g, yield 72%) was obtained in the same manner as in <Synthesis step 1-2> of the above Synthesis Example 1.
GC-Mass (이론치: 535.20 g/mol, 측정치: 535 g/mol)GC-Mass (calculated: 535.20 g / mol, measured: 535 g / mol)
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
[[ 합성예Synthetic example 3] 화합물 3] Compound InvInv -3의 합성Synthesis of -3
<합성단계 3-1> 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole의 합성<Synthesis Step 3-1> Synthesis of 1-phenyl-1,8-dihydrocarbazolo [4,3-c] carbazole
상기 합성예 2의 <합성단계 1-1>과 동일하게 수행하여, 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (4.43 g, 수율 71 %)을 얻었다. 1-phenyl-1,8-dihydrocarbazolo [4,3-c] carbazole (4.43 g, yield 71%) was obtained in the same manner as in <Synthesis step 1-1> of Synthesis Example 2.
<합성단계 3-2> 화합물 Inv-3의 합성<Synthesis step 3-2> Synthesis of compound Inv-3
합성예 1의 <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 2-bromo-4,6-diphenylpyridine (3.65 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-3 (3.36 g, 수율 70 %)를 얻었다.2-bromo-4,6-diphenylpyridine (3.65 g, 11.77 mmol) was used instead of the 2-bromo-4,6-diphenyl-1,3,5-triazine used in Synthesis Step 1-2 in Synthesis Example 1 , The compound Inv-3 (3.36 g, yield 70%) was obtained in the same manner as in <Synthesis step 1-2> of the above Synthesis Example 1.
GC-Mass (이론치: 611.24 g/mol, 측정치: 611 g/mol)GC-Mass (calculated: 611.24 g / mol, measured: 611 g / mol)
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
[[ 합성예Synthetic example 4] 화합물 4] Compound InvInv -4의 합성Synthesis of -4
<합성단계 4-1> 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole의 합성<Synthesis Step 4-1> Synthesis of 1-phenyl-1,8-dihydrocarbazolo [4,3-c] carbazole
상기 합성예 2의 <합성단계 1-1>과 동일하게 수행하여, 1-phenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (4.43 g, 수율 71 %)을 얻었다. 1-phenyl-1,8-dihydrocarbazolo [4,3-c] carbazole (4.43 g, yield 71%) was obtained in the same manner as in <Synthesis step 1-1> of Synthesis Example 2.
<합성단계 4-2> 화합물 Inv-4의 합성<Synthesis step 4-2> Synthesis of compound Inv-4
합성예 1의 <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 4-bromoisoquinoline (2.45 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-4 (2.72 g, 수율 68 %)를 얻었다.Except that 4-bromoisoquinoline (2.45 g, 11.77 mmol) was used instead of 2-bromo-4,6-diphenyl-1,3,5-triazine used in Synthesis Step 1-2 in Synthesis Example 1, Was carried out in the same manner as in <Synthesis step 1-2> of the above Synthesis Example 1 to obtain a compound Inv-4 (2.72 g, yield 68%).
GC-Mass (이론치: 509.19 g/mol, 측정치: 509 g/mol)GC-Mass (calculated: 509.19 g / mol, measured: 509 g / mol)
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
[[ 합성예Synthetic example 5] 화합물 5] Compound InvInv -5의 합성Synthesis of -5
질소 기류 하에서, 준비예 1에서 합성된 화합물 1,8-dihydrocarbazolo[4,3-c]carbazole (5 g, 16.32 mmol), 2-bromo-6-phenylpyridine (9.55 g, 40.80 mmol), Cu powder(0.1 g, 1.63 mmol), K2CO3(2.26 g, 16.32 mmol), Na2SO4(2.32 g, 16.32 mmol) 및 nitrobenzene(100 ml)를 혼합한 후, 190 ℃에서 12 시간 동안 교반하였다. 반응이 종결된 후, nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리한 다음, MgSO4를 사용하여 물을 제거하였다. 이후, 유기층의 용매를 제거한 후, 컬럼 크로마토그래피(Hexane:EA = 3:1 (v/v))로 정제하여 화합물 Inv-5 (6.5 g, 수율 65 %)를 얻었다.The compound 1,8-dihydrocarbazolo [4,3-c] carbazole (5 g, 16.32 mmol), 2-bromo-6-phenylpyridine (9.55 g, 40.80 mmol) and Cu powder 0.1 g, 1.63 mmol), K 2 CO 3 (2.26 g, 16.32 mmol), Na 2 SO 4 (2.32 g, 16.32 mmol) and nitrobenzene (100 ml) were mixed and stirred at 190 ° C for 12 hours. After the reaction was terminated, the nitrobenzene was removed, the organic layer was separated with methylene chloride, and then the water was removed using MgSO 4 . Then, the solvent of the organic layer was removed, and the residue was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain Compound Inv-5 (6.5 g, yield 65%).
GC-Mass (이론치: 612.23 g/mol, 측정치: 612 g/mol)GC-Mass (calculated: 612.23 g / mol, measured: 612 g / mol)
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
[[ 합성예Synthetic example 6] 화합물 6] compound InvInv -6의 합성Synthesis of -6
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 2에서 합성된 4,11-diphenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (3 g, 5.62 mmol)를 사용하고, 합성예 1의 <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 6-bromo-2,3'-bipyridine (1.98 g, 8.42 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-6 (2.05 g, 수율 53 %)을 얻었다.Diphenyl-1,8-dihydrocarbazolo [4,3-c] pyridine synthesized in Preparation Example 2 instead of 1,8-dihydrocarbazolo [4,3- c] carbazole (3 g, 5.62 mmol) instead of 2-bromo-4,6-diphenyl-1,3,5-triazine used in Synthesis Example 1-2, Synthesis Step 1-1 and Synthesis Step 1-2 of Synthesis Example 1 were repeated except that 2,3'-bipyridine (1.98 g, 8.42 mmol) was used to synthesize Compound Inv-6 (2.05 g, yield 53%).
GC-Mass (이론치: 688.26 g/mol, 측정치: 688 g/mol)GC-Mass (calculated: 688.26 g / mol, measured: 688 g / mol)
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
[[ 합성예Synthetic example 7] 화합물 7] Compound InvInv -7의 합성Synthesis of -7
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 2에서 합성된 4,11-diphenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (5 g, 10.90 mmol)를 사용하고, iodobenzene 대신 3-bromobiphenyl (3.81 g, 16.36 mmol)를 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 5-bromo-2,2'-bipyridine (1.73 g, 7.35 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-7 (1.95 g, 수율 52 %)을 얻었다.Diphenyl-1,8-dihydrocarbazolo [4,3-c] pyridine synthesized in Preparation Example 2 instead of 1,8-dihydrocarbazolo [4,3- 3-bromobiphenyl (3.81 g, 16.36 mmol) was used in place of iodobenzene and 2-bromo-4,6-diphenyl- <Synthesis step 1-1> and <Synthesis step 1> of Synthesis Example 1 were repeated except that 5-bromo-2,2'-bipyridine (1.73 g, 7.35 mmol) -2>, a compound Inv-7 (1.95 g, yield 52%) was obtained.
GC-Mass (이론치: 764.29 g/mol, 측정치: 764 g/mol)GC-Mass (calculated: 764.29 g / mol, measured: 764 g / mol)
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
[[ 합성예Synthetic example 8] 화합물 8] compound InvInv -8의 합성Synthesis of -8
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 2에서 합성된 4,11-diphenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (5 g, 10.90 mmol)를 사용하고, iodobenzene 대신 4-bromobiphenyl (3.81 g, 16.36 mmol)을 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.38 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-8 (2.4 g, 수율 58 %)을 얻었다.Diphenyl-1,8-dihydrocarbazolo [4,3-c] pyridine synthesized in Preparation Example 2 instead of 1,8-dihydrocarbazolo [4,3- bromo-4,6-diphenyl-3,6-dicarboxylate used in the synthesis step 1-2 was obtained by using 4-bromobiphenyl (3.81 g, 16.36 mmol) instead of iodobenzene, <Synthesis step 1-1> and <Synthesis step 1-2> of the above Synthesis Example 1 were repeated except that 2-bromo-4,6-diphenylpyrimidine (2.3 g, 7.38 mmol) was used instead of 1,3,5- 2> to obtain Compound Inv-8 (2.4 g, yield 58%).
GC-Mass (이론치: 840.33 g/mol, 측정치: 840 g/mol)GC-Mass (calculated: 840.33 g / mol, measured: 840 g / mol)
Elemental Analysis: C, 88.54; H, 4.79; N, 6.66
Elemental Analysis: C, 88.54; H, 4.79; N, 6.66
[[ 합성예Synthetic example 9] 화합물 9] compound InvInv -9의 합성Synthesis of -9
합성예 5에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 2에서 합성된 4,11-diphenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (3 g, 6.55 mmol)를 사용하고, 2-bromo-6-phenylpyridine 대신 2-bromo-4,6-diphenylpyrimidine (3.06 g, 9.82 mmol)을 사용하는 것을 제외하고는, 상기 합성예 5와 동일하게 수행하여 화합물 Inv-9 (3.37 g, 수율 56 %)을 얻었다.Diphenyl-1,8-dihydrocarbazolo [4,3-c] carbazole (3 g, 6.55) synthesized in Preparation Example 2 instead of 1,8-dihydrocarbazolo [4,3- mmol) and 2-bromo-4,6-diphenylpyrimidine (3.06 g, 9.82 mmol) was used instead of 2-bromo-6-phenylpyridine. 9 (3.37 g, yield 56%).
GC-Mass (이론치: 918.35 g/mol, 측정치: 918 g/mol)GC-Mass (calculated: 918.35 g / mol, measured: 918 g / mol)
Elemental Analysis: C, 86.25; H, 4.61; N, 9.14
Elemental Analysis: C, 86.25; H, 4.61; N, 9.14
[[ 합성예Synthetic example 10] 화합물 10] compound InvInv -10의 합성Synthesis of -10
합성예 5에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 2에서 합성된 4,11-diphenyl-1,8-dihydrocarbazolo[4,3-c]carbazole (3 g, 6.54 mmol)를 사용하고, 2-bromo-6-phenylpyridine 대신 4-bromo-N,N-diphenylaniline(3.18 g, 9.81 mmol)을 사용하는 것을 제외하고는, 상기 합성예 5와 동일하게 수행하여 화합물 Inv-10 (3.34 g, 수율 54 %)을 얻었다.Diphenyl-1,8-dihydrocarbazolo [4,3-c] carbazole (3 g, 6.54) synthesized in Preparation Example 2 instead of 1,8-dihydrocarbazolo [4,3- mmol) and 4-bromo-N, N-diphenylaniline (3.18 g, 9.81 mmol) was used in place of 2-bromo-6-phenylpyridine. 10 (3.34 g, yield 54%).
GC-Mass (이론치: 944.39 g/mol, 측정치: 944 g/mol)GC-Mass (944.39 g / mol, measured: 944 g / mol)
Elemental Analysis: C, 88.95; H, 5.12; N, 5.93
Elemental Analysis: C, 88.95; H, 5.12; N, 5.93
[[ 합성예Synthetic example 11] 화합물 11] compound InvInv -11의 합성Synthesis of -11
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 13,14-dihydrocarbazolo[1,2-a]carbazole (5 g, 16.32 mmol)를 사용하고, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 4-bromo-2-phenylpyrimidine(2.77 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-11 (2.15 g, 수율 51 %)을 얻었다.Dihydrocarbazolo [1,2-a] carbazole (prepared in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 in Synthesis Example 1 , 16.32 mmol) and 4-bromo-2-phenylpyrimidine (2.77 g, 11.77 mmol) instead of 2-bromo-4,6-diphenyl-1,3,5- (2.15 g, yield 51%) was obtained in the same manner as in < Synthesis Step 1-1 > and < Synthesis Step 1-2 >
GC-Mass (이론치: 536.20 g/mol, 측정치: 536 g/mol)GC-Mass (calculated: 536.20 g / mol, measured: 536 g / mol)
Elemental Analysis: C, 85.05; H, 4.51; N, 10.44
Elemental Analysis: C, 85.05; H, 4.51; N, 10.44
[[ 합성예Synthetic example 12] 화합물 12] compound InvInv -12의 합성Synthesis of -12
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 13,14-dihydrocarbazolo[1,2-a]carbazole 5 g, 16.32 mmol)를 사용하고, iodobenzene 대신 4-bromobiphenyl (5.71 g, 24.48 mmol)를 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 3-(4-bromophenyl)pyridine (2.3 g, 9.81 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-12 (1.72 g, 수율 43 %)을 얻었다.5 g of 13,14-dihydrocarbazolo [1,2-a] carbazole synthesized in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Step 1-1 of Synthesis Example 1, 16.32 mmol), 4-bromobiphenyl (5.71 g, 24.48 mmol) was used in the place of iodobenzene, and 2-bromo-4,6-diphenyl-1,3,5-triazine Synthesis step 1-1> and <Synthesis step 1-2> of Synthesis Example 1 were repeated except that 3- (4-bromophenyl) pyridine (2.3 g, 9.81 mmol) Inv-12 (1.72 g, yield 43%).
GC-Mass (이론치: 611.24 g/mol, 측정치: 611 g/mol)GC-Mass (calculated: 611.24 g / mol, measured: 611 g / mol)
Elemental Analysis: C, 88.35; H, 4.78; N, 6.87
Elemental Analysis: C, 88.35; H, 4.78; N, 6.87
[[ 합성예Synthetic example 13] 화합물 13] Compound InvInv -13의 합성Synthesis of -13
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 13,14-dihydrocarbazolo[1,2-a]carbazole 5 g, 16.32 mmol)를 사용하고, iodobenzene 대신 4-bromobiphenyl (5.71 g, 24.48 mmol)를 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 2-bromo-4,6-diphenylpyridine (3.04 g, 9.81 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-13 (1.85 g, 수율 41 %)을 얻었다.5 g of 13,14-dihydrocarbazolo [1,2-a] carbazole synthesized in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Step 1-1 of Synthesis Example 1, 16.32 mmol), 4-bromobiphenyl (5.71 g, 24.48 mmol) was used in the place of iodobenzene, and 2-bromo-4,6-diphenyl-1,3,5-triazine Synthesis step 1-1> and <Synthesis step 1-2> of Synthesis Example 1 were repeated except that 2-bromo-4,6-diphenylpyridine (3.04 g, 9.81 mmol) Compound Inv-13 (1.85 g, yield 41%) was obtained.
GC-Mass (이론치: 687.27 g/mol, 측정치: 687 g/mol)GC-Mass (687.27 g / mol, measured: 687 g / mol)
Elemental Analysis: C, 89.06; H, 4.84; N, 6.11
Elemental Analysis: C, 89.06; H, 4.84; N, 6.11
[[ 합성예Synthetic example 14] 화합물 14] Compound InvInv -14의 합성Synthesis of -14
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 13,14-dihydrocarbazolo[1,2-a]carbazole 5 g, 16.32 mmol)을 사용하고, iodobenzene 대신 1-(4-bromophenyl)naphthalene (6.93 g, 24.48 mmol)를 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 2-bromo-4,6-diphenyl-1,3,5-triazine (2.76 g, 8.85 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-14 (1.7 g, 수율 39 %)을 얻었다.5 g of 13,14-dihydrocarbazolo [1,2-a] carbazole synthesized in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Step 1-1 of Synthesis Example 1, 16.32 mmol) was used in place of iodobenzene and l- (4-bromophenyl) naphthalene (6.93 g, 24.48 mmol) was used in place of iodobenzene. <Synthesis step 1-1> of Synthesis Example 1 was repeated except that 2-bromo-4,6-diphenyl-1,3,5-triazine (2.76 g, 8.85 mmol) And <Synthesis step 1-2>, compound Inv-14 (1.7 g, yield 39%) was obtained.
GC-Mass (이론치: 739.27 g/mol, 측정치: 739 g/mol)GC-Mass (739.27 g / mol, measured: 739 g / mol)
Elemental Analysis: C, 86.04; H, 4.50; N, 9.47
Elemental Analysis: C, 86.04; H, 4.50; N, 9.47
[[ 합성예Synthetic example 15] 화합물 15] Compound InvInv -15의 합성Synthesis of -15
합성예 5에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 13,14-dihydrocarbazolo[1,2-a]carbazole (3 g, 9.79 mmol)를 사용하고, 2-bromo-6-phenylpyridine 대신 5-bromo-2-phenylpyrimidine(3.45 g, 14.69 mmol)을 사용하는 것을 제외하고는, 상기 합성예 5와 동일하게 수행하여 화합물 Inv-15 (3.31 g, 수율 55 %)을 얻었다.Dihydrocarbazolo [1,2-a] carbazole (3 g, 9.79 mmol) synthesized in Preparation Example 3 was used instead of 1,8-dihydrocarbazolo [4,3- Inv-15 (3.31 g, yield 55%) was obtained in the same manner as in Synthesis Example 5, except that 5-bromo-2-phenylpyrimidine (3.45 g, 14.69 mmol) was used in place of 2-bromo- ).
GC-Mass (이론치: 614.22 g/mol, 측정치: 614 g/mol)GC-Mass (theory: 614.22 g / mol, measured: 614 g / mol)
Elemental Analysis: C, 82.06; H, 4.26; N, 13.67
Elemental Analysis: C, 82.06; H, 4.26; N, 13.67
[[ 합성예Synthetic example 16] 화합물 16] compound InvInv -16의 합성Synthesis of -16
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 1,4-dihydrocarbazolo[2,3-b]carbazole (5 g, 16.32 mmol)을 사용하고, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 3-iodo-9-phenyl-9H-carbazole(4.34 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-16 (3.42 g, 수율 70 %)을 얻었다.Dihydrocarbazolo [2,3-b] carbazole (prepared in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 in Synthesis Example 1 , 16.32 mmol) was used in place of 2-bromo-4,6-diphenyl-1,3,5-triazine in Example 1 and 3-iodo-9-phenyl-9H- , Inv-16 (3.42 g, yield 70%) was obtained in the same manner as in <Synthesis step 1-1> and <Synthesis step 1-2> of the above Synthesis Example 1, .
GC-Mass (이론치: 623.24 g/mol, 측정치: 623 g/mol)GC-Mass (calculated: 623.24 g / mol, measured: 623 g / mol)
Elemental Analysis: C, 88.58; H, 4.69; N, 6.74
Elemental Analysis: C, 88.58; H, 4.69; N, 6.74
[[ 합성예Synthetic example 17] 화합물 17] Compound InvInv -17의 합성Synthesis of -17
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 1,4-dihydrocarbazolo[2,3-b]carbazole (5 g, 16.32 mmol)을 사용하고, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 2-bromo-5-phenylpyrimidine (2.77 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-17 (2.36 g, 수율 56 %)을 얻었다.Dihydrocarbazolo [2,3-b] carbazole (prepared in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 in Synthesis Example 1 , 16.32 mmol), 2-bromo-5-phenylpyrimidine (2.77 g, 11.77 mmol) was used instead of 2-bromo-4,6-diphenyl-1,3,5- (2.36 g, yield 56%) was obtained in the same manner as in < Synthesis step 1-1 > and < Synthesis step 1-2 >
GC-Mass (이론치: 536.20 g/mol, 측정치: 536 g/mol)GC-Mass (calculated: 536.20 g / mol, measured: 536 g / mol)
Elemental Analysis: C, 85.05; H, 4.51; N, 10.44
Elemental Analysis: C, 85.05; H, 4.51; N, 10.44
[[ 합성예Synthetic example 18] 화합물 18] compound InvInv -18의 합성Synthesis of -18
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 1,4-dihydrocarbazolo[2,3-b]carbazole (5 g, 16.32 mmol)을 사용하고, iodobenzene 대신 2-bromo-6-phenylpyridine(5.73 g, 24.48 mmol)을 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 2-bromoquinoline (2.04 g, 9.79 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-18 (2.22 g, 수율 58 %)을 얻었다.Dihydrocarbazolo [2,3-b] carbazole (prepared in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 in Synthesis Example 1 Bromo-4,6-diphenyl-1, 2-bromo-6-phenylpyridine (5.73 g, 24.48 mmol) was used instead of iodobenzene. Synthesis step 1-1] and <Synthesis step 1-2> of Synthesis Example 1, except that 2-bromoquinoline (2.04 g, 9.79 mmol) was used in place of 3,5-triazine, Inv-18 (2.22 g, yield 58%).
GC-Mass (이론치: 586.22 g/mol, 측정치: 586 g/mol)GC-Mass (calculated: 586.22 g / mol, measured: 586 g / mol)
Elemental Analysis: C, 85.98; H, 4.47; N, 9.55
Elemental Analysis: C, 85.98; H, 4.47; N, 9.55
[[ 합성예Synthetic example 19] 화합물 19] Compound InvInv -19의 합성-19 Synthesis
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 1,4-dihydrocarbazolo[2,3-b]carbazole (5 g, 16.32 mmol)을 사용하고, iodobenzene 대신 2-bromo-6-phenylpyridine(5.73 g, 24.48 mmol)를 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 4-bromo-N,N-diphenylaniline (3.17 g, 9.79 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-19 (2.94 g, 수율 64 %)을 얻었다.Dihydrocarbazolo [2,3-b] carbazole (prepared in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 in Synthesis Example 1 , 16.32 mmol), 2-bromo-6-phenylpyridine (5.73 g, 24.48 mmol) was used in place of iodobenzene, <Synthesis step 1-1> and <Synthesis step 1-2> of Synthesis Example 1 were repeated except that 4-bromo-N, N-diphenylaniline (3.17 g, 9.79 mmol) To obtain Compound Inv-19 (2.94 g, yield 64%).
GC-Mass (이론치: 702.28 g/mol, 측정치: 702 g/mol)GC-Mass (theory: 702.28 g / mol, measured: 702 g / mol)
Elemental Analysis: C, 87.15; H, 4.88; N, 7.97
Elemental Analysis: C, 87.15; H, 4.88; N, 7.97
[[ 합성예Synthetic example 20] 화합물 20] compound InvInv -20의 합성Synthesis of -20
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 3에서 합성된 1,4-dihydrocarbazolo[2,3-b]carbazole (5 g, 16.32 mmol)을 사용하고, iodobenzene 대신 5'-bromo-(1,1',3',1'')terphenyl (7.57 g, 24.48 mmol)를 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-20 (2.19 g, 수율 51 %)을 얻었다.Dihydrocarbazolo [2,3-b] carbazole (prepared in Preparation Example 3 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 in Synthesis Example 1 , 16.32 mmol) and that 5'-bromo- (1,1 ', 3', 1 ") terphenyl (7.57 g, 24.48 mmol) was used instead of iodobenzene. (Inv-20) (2.19 g, yield 51%) was obtained in the same manner as in Synthesis Step 1-1> and <Synthesis Step 1-2>.
GC-Mass (이론치: 765.29 g/mol, 측정치: 765 g/mol)GC-Mass (calculated: 765.29 g / mol, measured: 765 g / mol)
Elemental Analysis: C, 86.25; H, 4.61; N, 9.14
Elemental Analysis: C, 86.25; H, 4.61; N, 9.14
[[ 합성예Synthetic example 21] 화합물 21] Compound InvInv -21의 합성Synthesis of -21
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[2,1-a]carbazole (5 g, 16.32 mmol)을 사용하고, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 3-(4-bromophenyl)pyridine (2.75 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-21 (2.18 g, 수율 52 %)을 얻었다.Dihydrocarbazolo [2,1-a] carbazole synthesized in Preparation Example 4 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 of Synthesis Example 1 , 16.32 mmol) and 3- (4-bromophenyl) pyridine (2.75 g, 11.77 mmol) instead of 2-bromo-4,6-diphenyl-1,3,5- (2.18 g, yield 52%) was obtained in the same manner as in <Synthesis Step 1-1> and <Synthesis Step 1-2> of Synthesis Example 1,
GC-Mass (이론치: 535.20 g/mol, 측정치: 535 g/mol)GC-Mass (calculated: 535.20 g / mol, measured: 535 g / mol)
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
Elemental Analysis: C, 87.45; H, 4.70; N, 7.84
[[ 합성예Synthetic example 22] 화합물 22] compound InvInv -22의 합성Synthesis of -22
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[2,1-a]carbazole (5 g, 16.32 mmol)을 사용하고, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 4-bromo-N,N-diphenylaniline(3.81 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-22 (2.9 g, 수율 59 %)을 얻었다.Dihydrocarbazolo [2,1-a] carbazole synthesized in Preparation Example 4 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 of Synthesis Example 1 , 16.32 mmol) was used instead of 4-bromo-N, N-diphenylaniline (3.81 g, 11.77 (Inv-22) (2.9 g, yield 59%) was obtained in the same manner as in <Synthesis Step 1-1> and <Synthesis Step 1-2> of Synthesis Example 1,
GC-Mass (이론치: 625.25 g/mol, 측정치: 625 g/mol)GC-Mass (calculated: 625.25 g / mol, measured: 625 g / mol)
Elemental Analysis: C, 88.29; H, 4.99; N, 6.72
Elemental Analysis: C, 88.29; H, 4.99; N, 6.72
[[ 합성예Synthetic example 23] 화합물 23] Compound InvInv -23의 합성Synthesis of -23
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[2,1-a]carbazole (5 g, 16.32 mmol)을 사용하고, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 4-(4-bromophenyl)-3,5-diphenyl-4H-1,2,4-triazole (4.43 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-23 (2.55 g, 수율 48 %)을 얻었다.Dihydrocarbazolo [2,1-a] carbazole synthesized in Preparation Example 4 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 of Synthesis Example 1 , 16.32 mmol) was used in place of 2-bromo-4,6-diphenyl-1,3,5-triazine, and 4- (4-bromophenyl) -3,5- Synthesis step 1-1] and <Synthesis step 1-2> of Synthesis Example 1, except that 4H-1,2,4-triazole (4.43 g, 11.77 mmol) Inv-23 (2.55 g, yield 48%).
GC-Mass (이론치: 677.26 g/mol, 측정치: 677 g/mol)GC-Mass (calculated: 677.26 g / mol, measured: 677 g / mol)
Elemental Analysis: C, 85.06; H, 4.61; N, 10.33
Elemental Analysis: C, 85.06; H, 4.61; N, 10.33
[[ 합성예Synthetic example 24] 화합물 24] Compound InvInv -24의 합성Synthesis of -24
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[2,1-a]carbazole (5 g, 16.32 mmol)을 사용하고, iodobenzene 대신 2-bromonaphthalene(5.07 g, 24.48 mmol)을 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 2-bromo-6-phenylpyridine (2.44 g, 10.40 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-24 (1.75 g, 수율 43 %)을 얻었다.Dihydrocarbazolo [2,1-a] carbazole synthesized in Preparation Example 4 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 of Synthesis Example 1 , 16.32 mmol), 2-bromonaphthalene (5.07 g, 24.48 mmol) was used in place of iodobenzene and 2-bromo-4,6-diphenyl-1,3,5- Synthesis step 1-1] and <Synthesis step 1-2> of Synthesis Example 1, except that 2-bromo-6-phenylpyridine (2.44 g, 10.40 mmol) Inv-24 (1.75 g, yield 43%).
GC-Mass (이론치: 585.22 g/mol, 측정치: 585 g/mol)GC-Mass (calculated: 585.22 g / mol, measured: 585 g / mol)
Elemental Analysis: C, 88.18; H, 4.65; N, 7.17
Elemental Analysis: C, 88.18; H, 4.65; N, 7.17
[[ 합성예Synthetic example 25] 화합물 25] Compound InvInv -25의 합성Synthesis of -25
합성예 5에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[2,1-a]carbazole(3 g, 9.79 mmol)을 사용하고, 2-bromo-6-phenylpyridine 대신 2-bromoquinoline (3.06 g, 14.69 mmol)을 사용하는 것을 제외하고는, 상기 합성예 5와 동일하게 수행하여 화합물 Inv-25 (3.13 g, 수율 57 %)을 얻었다.Dihydrocarbazolo [2,1-a] carbazole (3 g, 9.79 mmol) synthesized in Preparation Example 4 was used in place of 1,8-dihydrocarbazolo [4,3- Inv-25 (3.13 g, yield 57%) was obtained in the same manner as in Synthesis Example 5, except that 2-bromoquinoline (3.06 g, 14.69 mmol) was used instead of 2-bromo-6-phenylpyridine.
GC-Mass (이론치: 560.20 g/mol, 측정치: 560 g/mol)GC-Mass (calculated: 560.20 g / mol, measured: 560 g / mol)
Elemental Analysis: C, 85.69; H, 4.31; N, 9.99
Elemental Analysis: C, 85.69; H, 4.31; N, 9.99
[[ 합성예Synthetic example 26] 화합물 26] compound InvInv -26의 합성Synthesis of -26
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[3,2-b]carbazole (5 g, 16.32 mmol)을 사용하고, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 1-(4-bromophenyl)-2-phenyl-1H-benzo[d]imidazole (4.11 g, 11.77 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-26 (3.42 g, 수율 67 %)을 얻었다.Dihydrocarbazolo [3,2-b] carbazole synthesized in Preparation Example 4 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 of Synthesis Example 1 , 16.32 mmol) was used in place of 2-bromo-4,6-diphenyl-1,3,5-triazine in place of 1- (4-bromophenyl) Syn-1-1] and <Synthesis 1-2> of Synthesis Example 1, except that benzo [d] imidazole (4.11 g, 11.77 mmol) 3.42 g, yield 67%).
GC-Mass (이론치: 650.25 g/mol, 측정치: 650 g/mol)GC-Mass (calculated: 650.25 g / mol, measured: 650 g / mol)
Elemental Analysis: C, 86.74; H, 4.65; N, 8.61
Elemental Analysis: C, 86.74; H, 4.65; N, 8.61
[[ 합성예Synthetic example 27] 화합물 27] Compound InvInv -27의 합성-27
합성예 1의 <합성단계 1-1>에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[3,2-b]carbazole (5 g, 16.32 mmol)을 사용하고, iodobenzene 대신 5'-bromo-(1,1',3',1'')terphenyl (7.57 g, 24.48 mmol)을 사용하며, <합성단계 1-2>에서 사용된 2-bromo-4,6-diphenyl-1,3,5-triazine 대신 2-bromo-4,6-diphenylpyridine (2.61 g, 8.42 mmol)을 사용하는 것을 제외하고는, 상기 합성예 1의 <합성단계 1-1> 및 <합성단계 1-2>와 동일하게 수행하여 화합물 Inv-27 (2.14 g, 수율 50 %)을 얻었다.Dihydrocarbazolo [3,2-b] carbazole synthesized in Preparation Example 4 instead of 1,8-dihydrocarbazolo [4,3-c] carbazole used in Synthesis Example 1-1 of Synthesis Example 1 , 16.32 mmol), 5'-bromo- (1,1 ', 3', 1 ") terphenyl (7.57 g, 24.48 mmol) was used in place of iodobenzene, Except that 2-bromo-4,6-diphenylpyridine (2.61 g, 8.42 mmol) was used in place of 2-bromo-4,6-diphenyl-1,3,5- 1-1 > and < Synthesis step 1-2 >, compound Inv-27 (2.14 g, yield 50%) was obtained.
GC-Mass (이론치: 763.30 g/mol, 측정치: 763 g/mol)GC-Mass (calculated: 763.30 g / mol, measured: 763 g / mol)
Elemental Analysis: C, 89.62; H, 4.88; N, 5.50
Elemental Analysis: C, 89.62; H, 4.88; N, 5.50
[[ 합성예Synthetic example 28] 화합물 28] Compound InvInv -28의 합성-28 Synthesis
합성예 5에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[3,2-b]carbazole (3 g, 9.79 mmol)을 사용하고, 2-bromo-6-phenylpyridine 대신 3,3'-(5-bromo-1,3-phenylene)dipyridine(4.57 g, 14.69 mmol)을 사용하는 것을 제외하고는, 상기 합성예 5와 동일하게 수행하여 화합물 Inv-28 (3.83 g, 수율 51 %)을 얻었다.Dihydrocarbazolo [3,2-b] carbazole (3 g, 9.79 mmol) synthesized in Preparation Example 4 was used instead of 1,8-dihydrocarbazolo [4,3- Except that 3,3 '- (5-bromo-1,3-phenylene) dipyridine (4.57 g, 14.69 mmol) was used in place of 2-bromo-6-phenylpyridine. Inv-28 (3.83 g, yield 51%).
GC-Mass (이론치: 766.28 g/mol, 측정치: 766 g/mol)GC-Mass (calculated: 766.28 g / mol, measured: 766 g / mol)
Elemental Analysis: C, 84.57; H, 4.47; N, 10.96
Elemental Analysis: C, 84.57; H, 4.47; N, 10.96
[[ 합성예Synthetic example 29] 화합물 29] Compound InvInv -29의 합성Synthesis of -29
합성예 5에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[3,2-b]carbazole (3 g, 9.79 mmol)을 사용하고, 2-bromo-6-phenylpyridine 대신 2-(4-bromophenyl)pyridine(3.44 g, 14.69 mmol)을 사용하는 것을 제외하고는, 상기 합성예 5와 동일하게 수행하여 화합물 Inv-29 (3 g, 수율 50 %)을 얻었다.Dihydrocarbazolo [3,2-b] carbazole (3 g, 9.79 mmol) synthesized in Preparation Example 4 was used instead of 1,8-dihydrocarbazolo [4,3- (3 g, yield 50%) was obtained in the same manner as in Synthesis Example 5, except that 2- (4-bromophenyl) pyridine (3.44 g, 14.69 mmol) was used in place of 2-bromo-6- %).
GC-Mass (이론치: 612.23 g/mol, 측정치: 612 g/mol)GC-Mass (calculated: 612.23 g / mol, measured: 612 g / mol)
Elemental Analysis: C, 86.25; H, 4.61; N, 9.14
Elemental Analysis: C, 86.25; H, 4.61; N, 9.14
[[ 합성예Synthetic example 30] 화합물 30] Compound InvInv -30의 합성Synthesis of -30
합성예 5에서 사용된 1,8-dihydrocarbazolo[4,3-c]carbazole 대신 준비예 4에서 합성된 5,12-dihydrocarbazolo[3,2-b]carbazole (3 g, 9.79 mmol)을 사용하고, 2-bromo-6-phenylpyridine 대신 3-bromoquinoline (3.06 g, 14.69 mmol)을사용하는 것을 제외하고는, 상기 합성예 5와 동일하게 수행하여 화합물 Inv-30 (3.13 g, 수율 57 %)을 얻었다.Dihydrocarbazolo [3,2-b] carbazole (3 g, 9.79 mmol) synthesized in Preparation Example 4 was used instead of 1,8-dihydrocarbazolo [4,3- Inv-30 (3.13 g, yield 57%) was obtained in the same manner as in Synthesis Example 5, except that 3-bromoquinoline (3.06 g, 14.69 mmol) was used instead of 2-bromo-6-phenylpyridine.
GC-Mass (이론치: 560.20 g/mol, 측정치: 560 g/mol)GC-Mass (calculated: 560.20 g / mol, measured: 560 g / mol)
Elemental Analysis: C, 85.69; H, 4.31; N, 9.99
Elemental Analysis: C, 85.69; H, 4.31; N, 9.99
[실시예 1] 유기 EL 소자의 제조[Example 1] Production of organic EL device
합성예 1에서 합성된 화합물 Inv-1를 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 하기와 같은 방법으로 녹색 유기 EL 소자를 제조하였다.The compound Inv-1 synthesized in Synthesis Example 1 was subjected to high-purity sublimation purification by a conventionally known method, and then a green organic EL device was produced in the following manner.
ITO (Indium tin oxide)가 1500 Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.Glass substrate coated with ITO (Indium tin oxide) thin film with thickness of 1500 Å was washed with distilled water ultrasonic wave. After the distilled water was washed, the substrate was ultrasonically washed with a solvent such as isopropyl alcohol, acetone, or methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405), the substrate was cleaned using UV for 5 minutes, .
상기와 같이 준비된 ITO 투명 전극(양극) 위에, 합성예 1의 화합물 Inv-1을 호스트로 이용하여, m-MTDATA(60 nm) / TCTA(80 nm) / Inv 화합물 + 10 % Ir(ppy)3(300nm)/ BCP(10 nm) / Alq3(30 nm) / LiF(1 nm) / Al (200 nm) 순으로 발광 소자를 구성하여 유기 EL 소자를 제조하였다. M-MTDATA (60 nm) / TCTA (80 nm) / Inv compound + 10% Ir (ppy) 3 on the ITO transparent electrode (anode) prepared above as a host using the compound Inv- (300 nm) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm).
m-MTDATA, TCTA, Ir(ppy)3 및 BCP의 구조는 각각 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 and BCP are as follows.
[실시예 2 ~ 30] 유기 EL 소자의 제조[Examples 2 to 30] Preparation of organic EL device
실시예 1에서 발광층 형성시 발광 호스트 물질로서 사용된 화합물 Inv-1 대신 합성예 2 내지 30에서 각각 합성된 화합물 Inv-2 내지 Inv-30을 사용하는 것을 제외하고는, 실시예 1과 동일하게 수행하여 유기 EL 소자를 제작하였다.Inv-2 to Inv-30 synthesized in Synthesis Examples 2 to 30, respectively, were used instead of the compound Inv-1 used as a luminescent host material in the formation of the light emitting layer in Example 1, Thereby preparing an organic EL device.
[비교예 1] 유기 EL 소자의 제작[Comparative Example 1] Fabrication of organic EL device
실시예 1에서 발광층 형성시 발광 호스트 물질로서 사용된 화합물 Inv-1 대신 CBP를 사용하는 것을 제외하고는, 실시예 1과 동일하게 수행하여 유기 EL 소자를 제작하였다. CBP의 구조는 하기와 같다. An organic EL device was fabricated in the same manner as in Example 1, except that CBP was used instead of the compound Inv-1 used as a luminescent host material in forming the light emitting layer in Example 1. The structure of CBP is as follows.
[평가예][Evaluation example]
실시예 1 내지 30, 및 비교예 1에서 각각 제조된 유기 EL 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.The driving voltage, current efficiency and emission peak at a current density of 10 mA / cm 2 were measured for the organic EL devices manufactured in Examples 1 to 30 and Comparative Example 1, respectively, and the results are shown in Table 1 below.
(V)Driving voltage
(V)
(nm)EL peak
(nm)
(cd/A)Current efficiency
(cd / A)
실험 결과, 본 발명에 따른 화학식 1로 표시되는 화합물(Inv-1 내지 Inv-30)을 발광층의 호스트 물질로 사용하는 실시예 1 ~ 30의 녹색 유기 EL 소자는 종래 CBP를 사용하는 비교예 1의 녹색 유기 EL 소자보다 전류효율 및 구동전압 면에서 우수한 성능을 나타내는 것을 확인할 수 있었다.
As a result of the experiment, the green organic EL devices of Examples 1 to 30 using the compounds (Inv-1 to Inv-30) represented by the formula (1) according to the present invention as the host material of the light emitting layer, It was confirmed that the organic EL device exhibited better current efficiency and better driving voltage than the green organic EL device.
이상을 통해 본 발명의 바람직한 실시예에 대하여 설명하였지만, 본 발명은 이에 한정되는 것이 아니고 특허청구범위와 발명의 상세한 설명의 범위 안에서 여러 가지로 변형하여 실시하는 것이 가능하고 이 또한 발명의 범주에 속하는 것은 당연하다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, It is natural.
Claims (8)
상기 1층 이상의 유기물층은 발광층을 포함하고,
상기 발광층은 하기 화학식 5로 표시되는 화합물을 포함하는 것이 특징인 유기 전계 발광 소자:
[화학식 5]
(상기 화학식 5에서,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 C6~C14의 아릴기, 및 치환 또는 비치환되고, 1~3개의 N을 함유하는 핵원자수 5~14의 헤테로아릴기로 이루어진 군에서 선택되며,
이때 상기 아릴기, 및 헤테로아릴기에는 각각 독립적으로 C6~C14의 아릴기, 및 1개의 N을 함유하는 핵원자수 5~14의 헤테로아릴기로 이루어진 군에서 선택된 하나 이상의 치환기가 도입될 수 있고, 복수개의 치환기는 각각 동일하거나 상이할 수 있으며;
R1 내지 R12는 각각 독립적으로 수소이다).1. An organic electroluminescent device comprising: (i) an anode, (ii) a cathode, and (iii) one or more organic layers sandwiched between the anode and the cathode,
Wherein the one or more organic layers include a light emitting layer,
Wherein the light emitting layer comprises a compound represented by the following formula (5): < EMI ID =
[Chemical Formula 5]
(In the above formula (5)
Ar 1 and Ar 2 each independently represent a substituted or unsubstituted C 6 to C 14 aryl group and a substituted or unsubstituted heteroaryl group having 5 to 14 nuclear atoms containing 1 to 3 N Lt; / RTI >
The aryl group and the heteroaryl group may each independently have at least one substituent selected from the group consisting of a C 6 to C 14 aryl group and a heteroaryl group having 5 to 14 nuclear atoms containing one N atom And a plurality of substituents may be the same or different;
And R 1 to R 12 are each independently hydrogen.
상기 1층 이상의 유기물층은 발광층을 포함하고,
상기 발광층은 하기 화합물 Inv-11 내지 Inv-15로 이루어진 군에서 선택된 화합물을 포함하는 것이 특징인 유기 전계 발광 소자:
1. An organic electroluminescent device comprising: (i) an anode, (ii) a cathode, and (iii) one or more organic layers sandwiched between the anode and the cathode,
Wherein the one or more organic layers include a light emitting layer,
Wherein the light emitting layer comprises a compound selected from the group consisting of the following compounds Inv-11 to Inv-15:
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110141688A KR101506761B1 (en) | 2011-12-23 | 2011-12-23 | Organic compound and organic electroluminescent devices using the same |
PCT/KR2012/011158 WO2013094999A2 (en) | 2011-12-23 | 2012-12-20 | Organic compound, and organic electroluminescent device using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110141688A KR101506761B1 (en) | 2011-12-23 | 2011-12-23 | Organic compound and organic electroluminescent devices using the same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140025211A Division KR101827039B1 (en) | 2014-03-03 | 2014-03-03 | Organic compound and organic electroluminescent devices using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130073700A KR20130073700A (en) | 2013-07-03 |
KR101506761B1 true KR101506761B1 (en) | 2015-03-30 |
Family
ID=48669663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110141688A KR101506761B1 (en) | 2011-12-23 | 2011-12-23 | Organic compound and organic electroluminescent devices using the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101506761B1 (en) |
WO (1) | WO2013094999A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101900287B1 (en) * | 2012-12-11 | 2018-09-19 | 덕산네오룩스 주식회사 | Compound for organic electronic element, organic electronic element using the same, and a electronic device thereof |
CN104513662A (en) * | 2013-09-30 | 2015-04-15 | 北京鼎材科技有限公司 | Organic light-emitting material and application thereof |
KR20150070475A (en) * | 2013-12-16 | 2015-06-25 | 롬엔드하스전자재료코리아유한회사 | Organic Electroluminescent Compounds and Organic Electroluminescent Device Comprising the Same |
KR102263057B1 (en) * | 2014-05-07 | 2021-06-09 | 삼성전자주식회사 | Condensed compound and organic light emitting device including the same |
KR102508566B1 (en) * | 2014-07-10 | 2023-03-13 | 롬엔드하스전자재료코리아유한회사 | Organic electroluminescent compound and organic electroluminescent device comprising the same |
CN104403662B (en) * | 2014-11-11 | 2016-06-22 | 中节能万润股份有限公司 | A kind of electroluminescent organic material and preparation method thereof, application |
KR20160063259A (en) | 2014-11-26 | 2016-06-03 | 삼성전자주식회사 | Organic Semiconductor Compound, Organic Thin Film Including Same and Electronic Device Including the Organic Thin Film |
CN104673276B (en) * | 2014-12-31 | 2017-05-31 | 固安鼎材科技有限公司 | A kind of luminous organic material and its application |
WO2018097937A1 (en) | 2016-11-23 | 2018-05-31 | E. I. Du Pont De Nemours And Company | Electroactive compounds |
KR102174388B1 (en) * | 2017-05-12 | 2020-11-04 | 주식회사 엘지화학 | Cyclic compound and organic light emitting device comprising the same |
CN111094295B (en) * | 2017-07-18 | 2022-05-17 | 株式会社Lg化学 | Novel compound and organic light emitting device comprising the same |
US11618757B2 (en) | 2017-10-20 | 2023-04-04 | Lg Chem, Ltd. | Polycyclic compound and organic light emitting element comprising same |
KR20190115412A (en) * | 2018-04-02 | 2019-10-11 | 롬엔드하스전자재료코리아유한회사 | Organic electroluminescent compound and organic electroluminescent device comprising the same |
WO2019194481A1 (en) * | 2018-04-02 | 2019-10-10 | Rohm And Haas Electronic Materials Korea Ltd. | Organic electroluminescent compound and organic electroluminescent device comprising the same |
CN110229051A (en) * | 2019-06-26 | 2019-09-13 | 四川师范大学 | The synthesis of nano-graphene San Ben Bing Pi disc liquid-crystal compounds and photism |
CN112142741B (en) * | 2019-06-26 | 2023-05-12 | 北京鼎材科技有限公司 | Compound and application thereof, and organic electroluminescent device comprising compound |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100007780A (en) * | 2008-07-14 | 2010-01-22 | 다우어드밴스드디스플레이머티리얼 유한회사 | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
WO2010110553A2 (en) | 2009-03-23 | 2010-09-30 | Dow Advanced Display Materials, Ltd. | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
WO2010126234A1 (en) | 2009-04-29 | 2010-11-04 | Dow Advanced Display Materials,Ltd. | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102264698B (en) * | 2008-12-23 | 2015-11-25 | 株式会社Luminano | Novel organic semi-conductor compound, its manufacture method and organic semiconductor composition, organic semiconductor thin film and element containing it |
-
2011
- 2011-12-23 KR KR1020110141688A patent/KR101506761B1/en active IP Right Grant
-
2012
- 2012-12-20 WO PCT/KR2012/011158 patent/WO2013094999A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100007780A (en) * | 2008-07-14 | 2010-01-22 | 다우어드밴스드디스플레이머티리얼 유한회사 | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
WO2010110553A2 (en) | 2009-03-23 | 2010-09-30 | Dow Advanced Display Materials, Ltd. | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
WO2010126234A1 (en) | 2009-04-29 | 2010-11-04 | Dow Advanced Display Materials,Ltd. | Novel organic electroluminescent compounds and organic electroluminescent device using the same |
Non-Patent Citations (2)
Title |
---|
Organic Letters, Vol. 12, No. 14, pp. 3164-3167 (2010) * |
Organic Letters, Vol. 12, No. 14, pp. 3164-3167 (2010)* |
Also Published As
Publication number | Publication date |
---|---|
WO2013094999A3 (en) | 2013-08-22 |
KR20130073700A (en) | 2013-07-03 |
WO2013094999A2 (en) | 2013-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101506761B1 (en) | Organic compound and organic electroluminescent devices using the same | |
KR101477344B1 (en) | Novel compound and organic electroluminescent device comprising the same | |
KR101560674B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101571591B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20120095832A (en) | Novel compounds and organic electro luminescence device using the same | |
KR101506793B1 (en) | Organic electro luminescence device | |
KR101571589B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101366492B1 (en) | Novel compound and organic electroluminescent device comprising the same | |
KR20150008678A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101577100B1 (en) | New compounds and organic electro luminescence device comprising the same | |
KR20130125182A (en) | Novel compounds and organic electro luminescence device using the same | |
KR101418147B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR101577099B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101827039B1 (en) | Organic compound and organic electroluminescent devices using the same | |
KR101390616B1 (en) | Novel compounds and organic electro luminescence device using the same | |
KR101376874B1 (en) | Novel compounds and organic electro luminescence device using the same | |
KR20140084413A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101561340B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR20150086107A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101612154B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20130109729A (en) | Novel compounds and organic electro luminescence device using the same | |
KR101390587B1 (en) | Organic compounds and organic electro luminescence device using the same | |
KR101577101B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101577098B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101571590B1 (en) | Organic compounds and organic electro luminescence device using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
FPAY | Annual fee payment |
Payment date: 20180209 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190211 Year of fee payment: 5 |